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1 Introduction 
 
Pregnancy toxaemia (ketosis) is a metabolic disorder of pregnant ewes which occurs 
during the late gestation. This happens as a result of the inability of the pregnant ewe 
to maintain an adequate energy balance for the fast growing maternal fetal unit 
(MARTENIUK and HERDT 1988). 
 
The disease is characterized by hyperketonaemia, hypoglycaemia, insulin resistance, 
and hyperlipidaemia (MYATT and MIODOVNIK 1999). Carrying multiple fetuses or 
a single fetus of a larger size predisposes ewes to pregnancy toxaemia (ANDREWS et 
al. 1996). The disease is associated with a higher rate of mortality and cause severe 
economic losses (ROBERT et al. 1989). 
 
The requirements for glucose considerably increase in the pregnant animal fetus, and 
uterus utilizes glucose as a major energy source (LINDSAY 1973). Energy deficient 
mobilization of lipid reserves results in a doubling of the plasma FFA, giving rise to 
fatty liver and increased ketone bodies in blood and urine (CHAIYABUTER et al. 
1982). 
 
Also in the late gestation period of clinically-healthy sheep, there is increased secre-
tion of ketone bodies in urine. There is also a higher increased concentration of BHB 
in blood (FÜRLL et al. 1998). 
Several studies have focused on factors associated with the marked metabolic changes 
occurring in late pregnancy, such as hypoglycaemia and hyperketonaemia. Recent 
studies (CONNOLLY et al. 2004) have indicated that the period of late pregnancy is 
probably accompanied by distinct hormonal changes that modify metabolic responses 
and change homeostasis adaptations of the whole body.  
 
Some studies have shown that hyperketonaemia significantly depresses hepatic glu-
cose production (SCHLUMBOHM and HARMEYER 2004), and can probably no 
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longer be regarded as a secondary disease sign. Instead, it appears that hyperketonae-
mia plays an essential role in the pathogenesis of disease. 
 
In late gestation of multiparous ewes, concentrations of ketone bodies in blood are of-
ten higher than they are during early lactation. Aside from hyperketonaemia, elevated 
concentration of FFA in plasma and hypoglycaemia represent typical features of preg-
nancy toxaemia (BICKHARDT et al. 1989, HENZE et al. 1994, HENZE et al. 1998). 
 
A key role for plasma cytokines has been hypothesized in pathogenesis of pregnancy 
toxaemia in sheep because a general inflammatory-response occurs with activation of 
leukocytes and elevation of cytokine production, along with abnormal activation of the 
clotting system in pregnancy toxaemia (CONRAD et al. 1998 and SACKS et al. 1999). 
 
Uteroplacental hypoxia in pregnancy toxaemia induces local expression and abnormal 
production of several inflammatory cytokines, including IL-1ß and TNFα in the pla-
centa (REDMAN and SARGENT 2005). Peripheral blood mononuclear cells exposed 
to hypoxia also produce IL-1α and TNFα (BENYO et al. 1997). Inflammatory and 
immunoregulatory cytokines in pregnancy toxaemia may originate from various 
sources, including peripheral mononuclear cells and fatal tissues, such as fetal villous 
tissues (DUDLY et al. 1996). Cytokines-including IL-1β, TNFα and MCP-1 are asso-
ciated with immune responses and implicated in the pathogenesis of pregnancy toxae-
mia. This is because of their roles in endothelial damage (AKOUM et al. 1995, CON-
RAD and BENYO 1997, CONRAD et al. 1998, REDMAN and SARGENT 2005, 
YARIM 2007). 
 
The objective of the present study was to investigate the different metabolic parame-
ters in apparently healthy pregnant ewes in late gestation, and to characterize the 
metabolic changes during this period. This was in order to check the interaction be-
tween the TNFα and fat metabolism, and to analyse TNFα concentration, which may 
serve as markers to early diagnosis of pregnancy toxaemia in sheep. 
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2 Review of literature 
 
2.1 Metabolic condition of ewes in the late pregnancy 
In late-pregnant sheep, energy and nitrogen demands of the rapidly growing fetus are 
mostly met by placental intake of glucose and amino acids. The resulting increase in 
maternal requirements for these nutrients is partly met by increased voluntary feed 
intake and partly by a series of metabolic adaptations. These include increased hepatic 
gluconeogenesis from endogenous substrates (STEEL and LENG 1973, WILSON et 
al. 1983), and mobilization of FFA from adipose tissues (VERNON et al. 1981). De-
velopment of gestational insulin resistance appears to be a key factor in these adapta-
tions, whereby glucose utilization is consequently reduced in maternal non-uterine tis-
sues (ODDY et al. 1985, HAY 1988, PETTERSON et al. 1993). 
 
Adipose tissue insulin responsiveness has also been reported to be reduced during late 
gestation as a result of down-regulation of insulin binding. In comparison, post-
receptor sensitivity/signalling of biolysis and FFA mobilization are apparently unaf-
fected (PETTERSON et al. 1994). An adaptive increase in insulin secretion is nor-
mally observed in the mid to late pregnant sheep and rats (LETURQUE et al. 1980, 
VERNON et al. 1981, OSGERBY et al. 2002, BONE and TAYLOR 1976), which can 
be due to an increased pancreatic β-cell proliferation (BONE and TAYLOR 1976, 
NIEUWENHUIZEN et al. 1997).  
BLONDEAU et al. (1999) have demonstrated that the ability to increase insulin secre-
tion during mid to late pregnancy (necessitated by the peripheral insulin resistance) 
can be impaired in four and eight months old female rats. If the rats previously have 
been exposed to UN in early pre and postnatal life. This group has further shown that 
β-cell proliferation in the head of the pancreas was decreased in the pregnant 8 month-
old rats exposed to early life UN, which explains the absence of an insulin secretion 
up-regulation in mid to late pregnancy (AVRIL et al. 2002). It is, therefore, reasonable 
to assume that malnutrition during very early life may have long-lasting negative con-
sequences for the capacity of the endocrine pancreas to cope with physiological condi-
tions, where the glucose-insulin homeostasis is challenged. 
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2.2 Metabolic disorders subacute and acute pregnancy Toxaemia (Ovine Ketosis) 
GAAL and FEKETE (1982) described two outbreaks of ketosis: The first lead to the 
deaths of 118 seemingly healthy ewes in a single flock of 760 animals that were preg-
nant with twins. They were four-five years old, mostly 10-14 days before expected 
parturition in the November and December. The second caused symptoms in eight 
ewes and death in four ewes (all pregnant with twin), three weeks before parturition in 
mid-March. They were among a smallholding flock of 30 animals. Until two to three 
weeks before lambing the large flock that had been kept in crowded pens with no ex-
ercise, they were fed rations that had a 30% excess in energy and 9% deficiency in 
protein; thereafter the rations were 13-15% deficient in energy and 60-65% deficient in 
protein. During the last quarter of pregnancy, the small flock, while adequately housed 
and exercised, had received rations that were 35% deficient in dry matter and 27% de-
ficient in energy but with a 53% excess in protein content. In both flocks, the only 
pathological finding in affected animals was fatty degeneration of peripheral hepatic 
lobules. Blood and urine biochemical values were measured in selected symptomatic 
and asymptomatic animals. The most significant changes (raised liver enzymes, low-
ered glucose and total cholesterol and urinary pH) occurred in the large flock. 
 
BICKHARDT (1988) recorded that ketosis in sheep is briefly summarized, and that 
differences between healthy and affected sheep (such as decreased feed intake, im-
paired rumen function, ataxia, increased heart-rate, increased plasma bilirubin and de-
creased plasma potassium) are described. Pathogenesis of sheep ketosis is unclear, but 
the main treatment goals are stimulation of feed intake, restoration of rumen function, 
and daily treatment with a mineral mix enriched with calcium lactate and potassium 
chloride. Mortality of ketosis was decreased to 34% by these measures applied over 
the previous five years, while five years before that, application of an intravenous glu-
cose infusion decreased mortality to 44%. 
 
SINGH et al. (1992) induced pregnancy toxaemia in 16 sheep in the third trimester of 
pregnancy by protamine zinc insulin along with semistarvation. The clinical symptoms 
included the following: anorexia, dullness, depression, weakness, drowsiness, stiffness 
of body, nervous symptoms, partial blindness, and the odor of ketones on the breath. 
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At the terminal stages, animals developed partial or complete blindness, convulsion, 
dyspnoea, lateral recumbency and fatal coma. The total period of illness extended from 
three to nine days. A significant decrease was observed in blood glucose, total serum 
protein, and albumin. A significant increase developed in the levels of ketone bodies, 
total volatile fatty acids, blood urea nitrogen creatinine, and cholesterol. 
 
HENZE et al. (1994) studied the concentrations of hormones, metabolites and electro-
lytes in the plasma of 45 ewes which were repeatedly examined during gestation (day 
80 to 149), and on the third day of lactation. Healthy single pregnant (n=8) and twin 
pregnant ewes (n=12) were compared with ewes with subclinical (BHB > 1.0 mmol/l, 
n=6), or clinical (BHB>1.6 mmol/l, n=19) ketosis. The concentrations of BHB, glu-
cose, calcium, sodium, and growth hormone in the plasma of the healthy animals were 
higher postpartum than antepartum, while the concentrations of inorganic phospho-
rous, cortisol, and total oestrogen were lower postpartum than they had been during 
pregnancy. In the pregnant ewes, the concentrations of BHB, bilirubin, total oestrogen 
and growth hormone in the plasma increased, while the concentration of insulin de-
creased with increasing numbers of fetuses. In comparison with the healthy twin preg-
nant ewes, the animals with subclinical and clinical pregnancy ketosis showed an in-
crease in values of bilirubin, glutamate dehydrogenase, somatotropin, total oestrogen, 
cortisol, and cortisol/insulin ratios, as well as decreased values of glucose, insulin, and 
potassium. Individual differences between animals within their groups were observed 
for the examined hormones as well as for glucose, calcium, sodium and potassium 
(analysis of variance). Aside from multiple pregnancy low insulin values, and high 
cortisol/insulin ratios (due to individual disposition), enhanced ketogenesis and disor-
der of glucostasis. 
 
HENZE et al. (1998) studied clinical signs and selected blood chemical parameters for 
214 ewes with pregnancy toxaemia (ketosis). 134 animals survived and 80 animals 
died. The animals that died were affected earlier in pregnancy (143±7 days) and the 
duration of disease was shorter (10±13 days) compared to animals that survived 
(146±8 and 14±9 days, respectively). The animals that died had more severe clinical 
signs and higher values of BHB (4.3±3.6 vs. 3.5±2.6 mmol/litre) and cortisol (72±98 
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vs. 52±80 nmol/l). They also had lower values of insulin (37±12 vs. 66±42 pmol/l) and 
potassium (4.1±1.0 vs. 4.4±1.0 mmol/litre) at the onset of disease, than did those 
which survived. Glucose levels did not differ between the two groups. Survival rates 
were 53.6% for 56 animals treated with glucose and fructose infusions, 62.7% for 126 
animals treated orally with glucose precursors and electrolytes, and 86.7% for 15 ani-
mals treated orally with glucose precursors and electrolytes and s.c. with insulin. It is 
concluded that insulin deficiency plays an important role in the pathogenesis of ketosis 
in sheep.  
 
LACETERA et al. (2001) determined the effects of moderate feed restriction, single or 
twin pregnancy, and subclinical pregnancy toxaemia (PT) on immune responses of 
ewes. 16 Sardinian ewes were used. Six weeks before lambing, ewes were assigned to 
1 of 2 groups (n = 8/group) matched for number of fetuses, body condition score, and 
plasma glucose, FFA, and BHB concentrations. Feed intake was restricted for one of 
the groups. Cell-mediated immunity was evaluated in vivo and in vitro. Humoral im-
munity was evaluated in vivo by determining production of IgG antibodies against 
keyhole limpet hemocyanin (KLH). Four ewes developed subclinical PT (plasma BHB 
concentration > 0.86 mmol/L without any clinical signs of disease). Whether feed was 
restricted and type of pregnancy (single vs twin) did not have any significant effects on 
cell-mediated and humoral immune responses. Ewes with subclinical PT had signifi-
cantly lower proliferation in vitro of phytohemagglutinin-stimulated peripheral blood 
mononuclear cells and significantly lower values for KLH-specific IgG than did 
healthy ewes. Plasma BHB and FFA concentrations were negatively correlated with in 
vitro proliferation of peripheral blood mononuclear cells; plasma FFA concentration 
was negatively correlated with values for KLH-specific IgG. Results suggest that sub-
clinical PT may be associated with impairments in cell-mediated and humoral immune 
responses in sheep. 
  
ROUBIES et al. (2003) investigated the incidence of subclinical ovine ketosis was per-
formed in two large sheep flocks in an agricultural region of central Greece. 64 ani-
mals were allocated in two study groups: group C consisted of 29 non-pregnant fe-
males and group S of 35 end-term pregnant ewes. The trial lasted six weeks, including 
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the immediate pre- and postpartal period. Blood samples were collected on weekly 
intervals and used for determining the concentrations of  BHB, acetoacetate [acetoace-
tic acid] (AcAc), glucose, total (TB) and conjugated (CB) bilirubin, calcium (Ca), in-
organic phosphorus (P), sodium (Na), potassium (K), magnesium (Mg), and the activ-
ity of sorbitol dehydrogenase [L-iditol dehydrogenase] (SDH), and  gamma-glutamyl 
transferase (gamma GT). All the animals remained clinically healthy throughout the 
trial and parturition was uneventful. 18 ewes of group S (51.4%) delivered one lamb, 
12 (34.3%) twins, 4 (11.4%) triplets and 1 (2.9%) 4 lambs. Although the overall 
evaluation of the biochemical analysis did not support the existence of subclinical ke-
tosis, blood glucose remained significantly lower (p<0.05) in group S sheep, with its 
lowest value (2.3±0.34 mmol/litre) recorded 1 week prior to parturition. Sporadic 
cases of subclinical hyperketonaemia may occur, despite optimal flock management. 
 
KOLB and KASKOUS (2004) mentioned that pregnancy ketosis develops in sheep 
and goats with multiple pregnancies when there is an insufficient intake of metabo-
lisable energy and low resorption of glucoplastic compounds, such as amino acids and 
propionate, during the last weeks of pregnancy. Prevention requires the administration 
of approximately 60 g propionate or propylene glycol for every animal per day, via the 
feed. Indicators of the severity of the disease are the concentration of ketone bodies, 
and a decrease in the concentration of insulin in the blood plasma. The reactions at the 
development of the disease and recommendations for treatment are included. 
 
EL-DIN et al. (2005) determined the clinical and biochemical changes in pregnant 
toxaemic native ewes from Sharkia governorate to help diagnose the disease during its 
early stages. The ewes were divided into three groups according to clinical findings: 
Group one, moderately affected (n=20); group two, severely affected (n=20); and 
Group 3, control (n=10). Two blood samples were taken from each of the healthy con-
trol and the diseased animals. The first blood samples were mixed with sodium salt of 
EDTA for haematological studies. Total red blood cell count, total white blood cell 
count, haemoglobin concentrations and packed cell volume were significantly higher 
(p≤0.01) in groups one and two compared to the healthy control. The other blood sam-
ples were collected in clean centrifuge tubes, in which serum was separated for bio-
 8
chemical examinations. Total ketone bodies, alanine aminotransferase, alkaline phos-
phatase and free fatty acids were significantly higher in groups one and two compared 
to the control group. However, their glucose, calcium, total protein, albumin, globulin, 
total cholesterol and triglycerides were significantly lower. Urine examination indi-
cated the presence of ketone bodies, glucose, and protein in pregnant toxaemic ewes. It 
is concluded that high concentrations of ketone bodies in the blood and urine, in addi-
tion to hypoglycaemia are markers for pregnancy toxaemia in ewes and early interfer-
ence is recommended to save the animal's life. 
 
CAL et al. (2006) evaluated the metabolic disorders related to pregnancy toxaemia in 
ewes under experimental starvation. 14 Corriedale ewes aged from four to six years 
were synchronized. Mating was considered as day 0 of gestation. At the 100th day of 
gestation, which was ultrasonographically confirmed, the ewes were randomly divided 
into two groups. The first and second groups were fed in natural and artificial grass-
lands, respectively. At 142 days of gestation, half of each group was starved for 48 
hours. Glycaemia, uraemia, cortisol, ketonuria and body weight were recorded. Starva-
tion during late gestation was not severe enough to produce metabolic alterations con-
sidered as characteristic of pregnancy toxaemia. Ewes with better energy storage un-
derwent a lower risk of developing the condition. Among the studied variables, urinary 
ketones were the earliest indicators of starvation-induced metabolic changes. 
 
SCHLUMBOHM and HARMEYER (2008) studied six ewes they were sequentially 
subjected to two types of hypoglycaemic stress, firstly by fasting for 14 hours and sec-
ondly through induction of moderate hyperketonaemia. Glucose kinetics was assessed 
in each animal during the dry non-gestational period, during late gestation, and during 
early lactation. Application of these stress factors was associated with variation of 
plasma glucose concentrations from 4.9 to 0.87 mmol/l. The plasma glucose concen-
tration was always directly related to the glucose production rate. The greatest stress-
induced reductions in glucose concentrations and glucose production rate were seen 
during late gestation in twin-bearing ewes. The decline in the glucose production rate 
after an overnight fast and during induced hyperketonaemia was greater in twin-
bearing ewes than in single-bearing ewes (59% and 43%, respectively, p<0.05). The 
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stress conditions resulted in the lowest levels of glucose concentration and glucose 
turnover rates in the stressed, hyperketonaemic, and late gestation twin-bearing ewes. 
This illustrates that the glucose homoeostatic system of ewes bearing twins is signifi-
cantly more susceptible to hypoglycaemic stress than that of ewes bearing single 
lambs. These findings also show that the primary cause of hypoglycaemia in late ges-
tation twin-pregnant ewes is an increased susceptibility to a stress related reduction in 
glucose production rate. This metabolic condition leaves the twin-pregnant ewe pre-
disposed for the development of pregnancy toxaemia.  
 
AL-MUJALLI et al. (2008) investigated the pregnancy toxaemia in ewes presented at 
the Veterinary Teaching Hospital, King Faisal University, Saudi Arabia between 1992 
and 2003. 27 ewes presented in the clinic in 2004 with the suspicious of pregnancy 
toxaemia were subjected to clinical and laboratory examinations. Blood samples for 
glucose level determination were taken from six ewes proved to have pregnancy tox-
aemia. Blood samples were collected from six healthy nonpregnant and six healthy 
pregnant ewes as control. The incidence of pregnancy toxaemia in 12 years ranged 
between 6.5-37%. The highest incidence was reported in 1998 (37%), while the lowest 
incidence was reported in 2003 (6.5%). The clinical manifestations showed by the six 
animals affected with toxaemia were mainly nervous manifestations. The level of 
blood glucose in ewes with pregnancy toxaemia was 1.02±0.14 mmol/l, while in 
healthy nonpregnant and pregnant animals were 2.95±0.65 mmol/l and 2.7±0.14 
mmol/l, respectively. It is concluded that the incidence of the disease between 1992 
and 2003 is low to moderate, and the disease has a significant effect on blood glucose 
level. 
 
GUPTA et al. (2008) studied haemogram in subclinical ketosis in 514 goats and 76 
sheep in an organized farming system. In normal physiological states TEC, Hb and 
PCV showed a decrease in values during pregnancy and lactation states. This indicates 
anemia in the last month of pregnancy. TLC levels were increased in both pregnancy 
and lactation as compared to dry period. TEC, Hb, PCV and MCV did not show any 
significant changes in sub-clinical ketotic cases in either species of animals under in-
vestigation compared to healthy group animals. TLC values also showed non-
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significant changes in ketotic goats and sheep during pregnancy and lactation, though 
a mild-leucopenia was recorded. The study indicated that haemogram did not signifi-
cantly change in sub-clinical ketosis in sheep and goats.  
 
2.3 The importance and dynamic of the different biochemical parameters: glu-
cose, insulin, free fatty acids, β-hydroxybutyrate of ewes in the late pregnancy  
2.3.1 Glucose 
BICKHARDT et al. (1989) determined glucose metabolism in 17 healthy ewes during 
different metabolic stages and in eight spontaneously ketotic sheep by the IVGTT with 
low doses of glucose (0.8 mmol/kg). The endogenous turnover rate (R) was calculated 
by using the total clearance (Cl), derived from the IVGTT. The values of R, deter-
mined in healthy ewes by this technique are in agreement with values presented in the 
literature, which were derived from kinetic studies with 3H- or 14C-labeled glucose. 
There were no differences in the mean values of R and Cl in non-pregnant, highly 
pregnant and ketotic ewes. The plasma concentration of glucose (C) was directly cor-
related with R in highly pregnant healthy and ketotic ewes; there was no correlation in 
the group of non-pregnant and early pregnant sheep. In highly pregnant ketotic ewes 
the mean value of C was lower than in healthy ewes but there was no significant corre-
lation between the plasma concentration of glucose and that of BHB. It is concluded 
from the study, that the control of glucostasis fails frequently during late pregnancy in 
ewes and that ketosis of sheep is related closer to the excessive lipid mobilization than 
to disturbance of glucostasis. 
PETTERSON et al. (1993) measured the whole-body kinetics of glucose metabolism 
in nonpregnant and late-pregnant ditocous ewes which were fed either to maintain zero 
energy balance in maternal tissues (fed) or at 50% of this level (underfed) for several 
weeks. Whole-body kinetics of glucose metabolism was measured under basal condi-
tions, and the hyperinsulinemic, euglycemic clamp technique was used to define insu-
lin-dose response profiles for several indices of whole-body glucose utilization, and 
for endogenous glucose production. Pregnancy increased and undernutrition decreased 
basal glucose entry rate (GER), glucose metabolic clearance rate (GMCR) and insulin-
independent glucose utilization (IIGU). The consistent increment in IIGU of pregnant 
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over nonpregnant ewes was comparable to previous estimates of uterine glucose up-
take. Pregnancy resulted in higher plasma concentration for 50% maximal responses 
(ED50) to insulin of GER, GMCR, and steady-state glucose infusion rate (SSGIR) to 
maintain euglycemia and insulin-dependent glucose utilization (IDGU). These changes 
were especially large in underfed pregnant ewes. Effects on the maximal response to 
insulin of these variables (Rmax) were relatively small (GMCR, IDGU) and nonsig-
nificant (GER, SSGIR). Maximum insulin-induced suppression of endogenous glucose 
production was significantly lower due to undernutrition; neither Rmax nor ED50 for 
this response was affected by pregnancy. Insulin resistance in late-pregnant ewes is 
primarily due to decreased insulin sensitivity in (presumably) peripheral tissues, im-
plying an alteration of receptor function or of early postreceptor signal transduction. 
SCOTT et al. (1995) determined cerebrospinal fluid (CSF) and plasma glucose con-
centrations of spontaneous ovine pregnancy toxaemia cases within 24 hours of the on-
set of clinical signs, were significantly lower (p<0.01) compared to inappetent ewes 
and healthy ewes at a similar stage of gestation. When the data from the three groups 
were combined a highly significant correlation (p<0.001, r=0.91) was present between 
the plasma and CSF glucose concentrations. The data suggest that plasma glucose 
concentration accurately reflects CSF glucose concentration across the range of energy 
states in pregnant ewes and may provide support for the postulate that the neurological 
signs of ovine pregnancy toxaemia result from cerebral hypoglycaemia, as reflected by 
CSF glucose concentration. No cerebral glucose estimations were undertaken in this 
series. 
 
EHRHARDT and BELL (1997) analysed glucose transport concentration in six twin 
pregnant ewes on days 75, 110, and 140 postcoitus the glucose transporter (GT) con-
centration (pmol/mg protein) of D-glucose-inhibitable binding sites, measured by 
[3H]cytochalasin B binding analysis, increased 3.4 times from mid- to late pregnancy. 
Concurrently, an abundance of GLUT-1 and GLUT-3 protein, measured by immuno 
blotting with specific polyclonal antibodies, increased 2.3 and 2.9 times, respectively, 
while abundance of GLUT-1 and GLUT-3 mRNA, measured by Northern blotting, 
increased 1.8 and 3.9 times, respectively. GLUT-4 protein was undetectable at all 
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stages of pregnancy. Quantitative immuno blotting indicated that GLUT-1 accounted 
for 86.8±1.6% at day 75 and 56.1±4.1% on day 140 of total cytochalasin B binding 
sites. Thus increases in GT concentration explain much of the gestational increase in 
glucose transfer capacity observed in vivo. The gestational decline in relative contribu-
tion of GLUT-1 to cytochalasin binding, together with the greater developmental in-
creases in GLUT-3 mRNA and protein, further suggests that the relative importance of 
GLUT-3 increases with gestational age. 
 
SCHLUMBOHM et al. (1997) investigated glucose turnover in nine ewes during three 
reproductive states in order to examine their importance for development of subclini-
cal ketosis. The increase of insulin in plasma was measured after a continuous 60 min 
intravenous infusion of glucose (4.9 mmol. min-1). Turnover of glucose and insulin 
clearance were quantified during a combined euglycemic, hyperinsulinemic clamp. 
Insulin was consecutively infused in doses of 5 and 10 mU. kg-1. Min-1 for about 2.5 
hours, each. Plasma glucose concentration was adjusted to 5.3 to 5.8 mmol/l. The indi-
cators of glucose and lipid metabolism which were examined in this study showed 
marked individual variation, particularly during late pregnancy. The marked changes 
of these indicators with reproductive stages as well as their great variation between 
individual sheep support the assumption that they are of significance for the develop-
ment of pregnancy toxaemia in sheep. 
 
2.3.2 Insulin 
The endocrine system, especially the pancreas is directly involved in the development 
of ruminant ketosis. This review considers the role of the major pancreatic hormone 
insulin, in the pathogenesis of ruminant ketosis. However, since key information in 
ruminant animals is often lacking references to more abundant studies in nonruminant 
animals are used. Extrapolations from findings in diabetes mellitus are taken to fill 
gaps in our understanding of the roles of pancreatic hormones in the pathogenesis of 
ruminant ketosis. This is done, not because of the similarity in pathogenesis of these 
conditions, but rather because the alloxan diabetic animal serves as a model to study 
insulin. Insulin has long been associated with the ketoacidosis of diabetes mellitus. It 
is known to influence a) the mobilization of FFA from adipose tissue and b) utilization 
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of keton bodies by peripheral tissues. The lipogenic effect of insulin is well-recognized 
(BROCKMAN 1978). A fall in plasma insulin concentration triggers lipolysis in adi-
pose tissue and elevates plasma FFA concentration. However, lipid mobilization is not 
a major ketogenic stimulus without a contribution from the liver (MAYES and FELTS 
1967) Insulin inhibits ketogenesis when FFA levels remain high (BIEBERDORF et al. 
1970). During starvation and/or ketosis, hepatic removal of FFA is increased (KATZ 
and BERGMAN 1969) and a greater proportion of FFA is converted to BHB by the 
liver than normally. Insulin also appears to be important in regulating the utilization of 
BHB. The uptakes of BHB and acetate by the sheep hind limb are impaired during 
alloxan diabetes and are restored by insulin (JARRET et al 1974).  
HAY et al. (1988) tested the hypothesis that pregnancy in sheep alters the effects of 
insulin on glucose utilization and glucose production. Euglycemic, hyperinsulinemic 
glucose clamp experiments were performed in chronically catheterized, unstressed, fed 
or 24 hours fasted, nonpregnant sheep and fed, pregnant sheep. Endogenous glucose 
production rate for the whole sheep and glucose utilization rate of the uterine and 
nonuterine maternal tissues were measured in control and high-insulin periods by 
tracer technique using [6-3H]glucose. Control glucose utilization rate in the fed, non-
pregnant sheep was significantly (p<0.05) greater than that in the fasted, nonpregnant 
sheep, 2.29±0.17 and 1.86±0.11 mg/min/kg, respectively, and also in the nonuterine 
maternal tissues of the pregnant sheep (1.71±0.18 mg/min/kg). Insulin stimulated glu-
cose utilization 116.4±14.8% in the fed, nonpregnant sheep but only 82.8±11.0% in 
the fasted, nonpregnant sheep and 94.2±14.3% in the nonuterine tissues of the fed, 
pregnant sheep. Also, insulin suppressed endogenous glucose production to 53.2±5.6% 
in the fed, nonpregnant sheep, to 3.9±3.1% in the fasted, nonpregnant sheep, and to 
9.0±3.7% in the fed, pregnant sheep. In the pregnant animals, uterine glucose uptake 
and uterine glucose utilization were not different and were not altered by changes in 
maternal insulin concentration. The results indicate that during late pregnancy glucose 
utilization is reduced and resistance to the effect of insulin to enhance glucose utiliza-
tion is present in the nonuterine maternal tissues compared to nonpregnant, fed sheep. 
In contrast, the effectiveness of insulin to suppress glucose production in the pregnant 
sheep is greater than that in nonpregnant, fed sheep. These results also demonstrate 
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that differential changes in the effect of insulin can exist simultaneously between pe-
ripheral (glucose consuming) and central (glucose producing) tissues. The changes in 
glucose utilization and in insulin effect in the pregnant sheep are both qualitatively and 
quantitatively similar to those of the nonpregnant sheep when fasted, suggesting that 
similar substrate and/or hormonal factors may be involved. 
 
PETTERSON et al. (1994) studied the development of insulin resistance in late preg-
nancy in ewes which were fed either to maintain zero energy balance in maternal tis-
sues (fed) or at 50% of this level (underfed) for several weeks. Plasma concentrations 
of free fatty acids (FFA) and glycerol were measured under basal conditions and dur-
ing infusion of various doses of insulin while maintaining euglycemia (hyperinsu-
linemic, euglycemic clamp technique). Pregnancy and undernutrition separately in-
creased basal plasma FFA concentration in an additive manner; plasma glycerol was 
increased by pregnancy but unaffected by undernutrition. The molar ratio of FFA to 
glycerol was significantly greater in underfed ewes. Analysis of dose-response rela-
tions between plasma insulin and metabolites during insulin infusions showed that 
maximally insulin-suppressed concentrations of FFA and glycerol were significantly 
greater in pregnant than in nonpregnant ewes but were unaffected by undernutrition. 
Neither pregnancy nor undernutrition affected the maximally insulin-suppressed FFA 
to glycerol ratio, or the plasma insulin concentration for 50% maximal responses to 
insulin of plasma FFA, plasma glycerol, or the plasma FFA to glycerol ratio. Thus, 
even in ewes at or close to zero energy balance, pregnancy seems to reduce adipose 
responsiveness but not sensitivity to the antilipolytic effect of insulin. This is another 
manifestation of the normal development of insulin resistance in maternal tissues dur-
ing late pregnancy 
HENZE et al. (1998) examined 214 ewes suffering from pregnancy toxaemia (ketosis). 
Clinical signs during onset and course of disease and laboratory findings were com-
pared between animals that survived and those which died. The latter onset of ketosis 
was earlier in pregnancy (day 143±7 vs. day 146±8) and duration of the disease was 
shorter (10±13 vs. 14 ± 9 days). The animals that died showed more severe clinical 
signs and higher values of BHB (4.3±3.6 vs. 3.5±2.6 mmol/l) and cortisol (72±98 vs. 
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52±80 mmol/l) as well as lower values of insulin (37±12 vs. 3.5±2.6 mmol/l) and po-
tassium (4.1±1.0 vs. 4.4±1.0 mmol/1) at onset of the disease than those which survived 
(all of differences with p<0.05). Glucose levels did not differ between groups. Treated 
animals with glucose plus fructose infusions (n=56) or with oral application of glucose 
precursors plus electrolytes (n=126) had survival rates of 53.6% and 62.7%, respec-
tively. Oral treatment with glucose precursors plus electrolytes and an additional sub-
cutaneous insulin treatment (n=15) led to an enhanced survival rate of 86.7% (p<0.05). 
Low insulin levels in ketotic pregnant sheep and the therapeutic effect of insulin 
treatment support the hypothesis that insulin plays a causative role in the pathogenesis 
of ovine ketosis. 
KULCSAR et al. (2006) diagnosed ketosis in a flock of Merino ewes that conceived 
from synchronised oestrus in the early autumn period. On day 140 of pregnancy the 
ewes were sampled for determination of BHB, AST, glucose, FFA, total cholesterol 
(TCH), insulin, T4, T3, cortisol, IGF-1 and leptin. The results were evaluated accord-
ing to the number of fetuses born some days later and the presence of hyperketonaemia 
(BHB ≥1.60 mmol/l). In May, about three months after lambing, cyclic ovarian func-
tion was induced (Cronolone + eCG), and the ewes were artificially inseminated (AI) 
48 h after the removal of gestagen-containing sponge. At the time of AI and 10 days 
later blood samples were collected again to check the plasma levels of the same con-
stituents as previously (in samples taken at AI), and to monitor the ovarian response by 
assaying progesterone (in both samples). On day 140 of gestation significantly lower 
BHB levels were detected in dams with single (n=41) than in those with twin (n=57) 
pregnancies. Hyperketonaemia was found only in ewes bearing twins (n=27). These 
animals had higher FFA and cortisol, and lower TCH, insulin, IGF-1, leptin and T3 
levels than their normoketonaemic twin-bearing flock-mates, and those with single 
pregnancy. The blood glucose concentrations varied within a wide range, and the 
means of groups did not exhibit any significant differences. The formerly hyperke-
tonaemic individuals were characterized by lower leptin level three months after lamb-
ing, and they showed a poorer response to the cycle-induction procedure than the oth-
ers. The non-responders had lower IGF-1 and leptin levels than those ovulated after 
this treatment. It was concluded that the subclinical form of ovine ketosis is character-
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ized by complex endocrine alterations, reflecting an obvious form of negative energy 
balance. If attempts to induce cyclic ovarian function outside the breeding season are 
made soon after lambing, the ovarian response and fertility of these ewes may also be 
depressed. 
HAYIRLI (2006) studied the changes in nutritional and metabolic status during the 
periparturient period predispose dairy cattle to develop hepatic lipidosis and ketosis. 
The metabolic profile during early lactation includes low concentrations of serum in-
sulin, plasma glucose, and liver glycogen and high concentrations of serum glucagon, 
adrenaline, growth hormone, plasma BHB and FFA, and liver triglyceride. Moreover, 
during late gestation and early lactation, flow of nutrients to fetus and mammary tis-
sues are accorded a high degree of metabolic priority. This priority coincides with 
lowered responsiveness and sensitivity of extra hepatic tissues to insulin, which pre-
sumably plays a key role in development of hepatic lipidosis and ketosis. Hepatic lipi-
dosis and ketosis compromise production, immune function, and fertility. Cows with 
hepatic lipidosis and ketosis have low tissue responsiveness to insulin owing to keto-
acidosis. Insulin has numerous roles in metabolism of carbohydrates, lipids and pro-
teins. Insulin is an anabolic hormone and acts to preserve nutrients as well as being a 
potent feed intake regulator. In addition to the major replacement therapy to alleviate 
severity of negative energy balance, administration of insulin with concomitant deliv-
ery of dextrose increases efficiency of treatment for hepatic lipidosis and ketosis. 
However, data on use of insulin to prevent these lipid-related metabolic disorders are 
limited and it should be investigated. 
2.3.3 β-hydroxybutyrate (BHB) 
BICKHARDT et al. (1988) mentioned that the plasma concentration of BHB was 
negatively correlated with substrate concentrations of glucose metabolism, but posi-
tively correlated with the triglyceride content of the liver and with the plasma concen-
tration of bilirubin. It is concluded that an increase of the plasma concentration of 
BHB is a sensitive indicator of the complex alteration of glucose and lipid metabolism 
in ketosis of sheep. 
BICKHARDT (1989) estimated plasma glucose and BHB concentrations in 142 
healthy and 119 ketotic ewes. Plasma glucose values were lower in twin pregnant 
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German Blackheaded Mutton and Merino sheep and in pregnant Heidschnucke than in 
non-pregnant ewes, or ewes in early pregnancy of these breeds. There were no such 
differences at different stages of the reproductive cycle in healthy East Friesian ewes. 
Plasma glucose concentrations did not vary between breeds. Plasma glucose concen-
trations varied three fold in ketotic ewes compared with healthy ones, but mean values 
were not significantly different. Plasma BHB concentrations differed significantly be-
tween healthy ewes of different breeds and were highest in German Blackheaded Mut-
ton and Merino ewes in late pregnancy and during lactation. There were more German 
Blackheaded Mutton and Merino ewes in the ketotic group than would be expected 
from the breed distribution in the area. Plasma BHB concentrations were higher in ke-
totic than in healthy ewes. It is concluded that individual variation and breed were 
more important causes of ketosis than insufficient feed supply. Multiple pregnant 
German Blackheaded Mutton and Merino sheep were particularly susceptible. 
 
HENZE et al. (1994) examined the concentrations of hormones, metabolites and elec-
trolytes in plasma of 45 ewes during gestation (day 80 to 149) and on the 3rd day of 
lactation. Healthy single pregnant (n=8) and twin pregnant ewes (n=12) were com-
pared with ewes with subclinical (BHB>1.0 mmol/l, n=6) or clinical BHB>1.6 mmol/l, 
n=19) ketosis. The concentration of BHB, glucose, calcium, sodium and growth hor-
mone in the plasma of the healthy animals were higher postpartum than ante-partum, 
while the concentrations of inorganic phosphorous, cortisol and total oestrogen were 
lower postpartum than during pregnancy. In the pregnant ewes the concentrations of 
BHB, bilirubin, total oestrogen and growth hormone in the plasma increased, while the 
concentration of insulin decreased with increasing numbers of fetuses. In comparison 
with the healthy twin pregnant ewes the animals with subclinical and clinical preg-
nancy ketosis showed increased values of bilirubin, glutamate dehydrogenase, somato-
tropin, total oestrogen, cortisol and cortisol/insulin ratios as well as decreased values 
of glucose, insulin and potassium. Individual differences between animals within their 
groups were observed for the examined hormones as well as for glucose, calcium, so-
dium and potassium (analysis of variance). Beside multiple pregnancy low insulin val-
ues and high cortisol/insulin ratios, due to individual disposition, influence enhanced 
ketogenesis and disorder of glucostasis. 
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FRAT and OZPNAR (2002) examined 20 synchronized ewes from Sakiz, Turkey, 
aged 3-4 years. Blood samples were taken once in pre-pregnancy and at the 100th day 
of pregnancy. On the 120th day of pregnancy and on the 10th day of lactation, blood 
samples were collected every 2 hours for 24 hours from only ten ewes. Plasma cortisol 
levels were analysed by radioimmunoassay. Plasma glucose and BHB levels were de-
termined spectrophotometrically. Plasma cortisol level slightly increased at the 100th 
day of pregnancy, decreased during late pregnancy and continued to decrease during 
lactation. Plasma glucose and BHB levels were not significantly different during pre-
pregnancy, pregnancy and the early lactation periods. It is concluded that metabolic 
disorders such as pregnancy toxaemia does not occur in ewes fed a balanced ration 
sufficient in energy and protein levels even in a multiple lambing breed of ewes. 
HARMEYER and SCHLUMBOHM (2006) examined the impact of pregnancy on ke-
tone body disposal during a hyperketonaemic clamp by tracer isotope dilution tech-
niques in seven 12 hours fasted sheep in three reproductive states, in the dry non-
gestation period, late in gestation and during early lactation. After a sampling period of 
60 minutes under basal conditions BHB racemate solution was continuously infused 
intravenously for 3 hours at rates of 14.3-24.3  micro mol/(kg min) to elevate the BHB 
concentration in blood plasma to values between 5 and 7 mmol/l. Two separate ex-
periments were carried out with the same sheep in each of the three reproductive 
states. During pregnancy three ewes were pregnant with a single lamb and four ewes 
carried twins. Maximal BHB turnover rates fell significantly in late gestation by 26% 
relative to early lactation and by 22% when compared with the dry non-pregnant state. 
Reduction of maximal BHB disposal rate during late gestation was accompanied by a 
significant 297% (p<0.005) and a non-significant 49% increase in the basal BHB con-
centration in blood, a non-significant 10% and 4% decrease in the rate constant of 
BHB turnover and a non-significant 24% and 13% rise in the incremented increase of 
BHB concentration per unit BHB infusion, relative to the dry and the lowered FFA 
lactating period, respectively. Induction of hyperketonaemia significantly and glycerol 
concentrations in blood by 67% and 57%, respectively, compared to the pre-infusional 
concentrations. The magnitude of this effect was the same in all reproductive states 
and was explained as a direct antilipolytic action of BHB on adipose tissue. It is con-
cluded that the reduced ability of the late gestating ewe to utilize BHB promotes hy-
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perketonaemia. Since hyperketonaemia exerts several adverse effects, e.g. on energy 
balance and glucose metabolism it appears that the impairment of ketone bodies dis-
posal in late pregnancy facilitates development of pregnancy toxaemia, especially in 
ewes carrying twins 
RAMIN et al. (2007) determined the distribution of subclinical pregnancy toxaemia by 
evaluation of serum glucose, BHB, urea and cortisol concentrations in pregnant ewes. 
809 blood samples were collected from the jugular veins of 497 pregnant, 242 lambed 
and 70 aborted ewes. They were apparently healthy without any signs of disease. The 
concentrations of BHB, glucose and urea were assessed by spectrophotometry and cor-
tisol by ELISA. Mean serum glucose (mg/dl), BHB (mmol/litre), urea (mg/dl) and cor-
tisol (ng/ml) concentrations in pregnant ewes were 35.1, 0.45, 33.1 and 22.4; in 
lambed ewes were 35.7, 0.44, 30.0 and 13.5 and in aborted ewes were 41.4, 0.4, 28.6 
and 24, respectively. Mean urea and BHB concentrations in pregnant ewes were 
greater and glucose was lower than in lambed and aborted ewes. Cortisol concentra-
tions in pregnant ewes were higher than in the lambed but lower than in aborted ewes. 
Mean comparison of parameters showed a significant difference (p<0.01) except for 
BHB. The BHB concentrations were similar in all groups. A negative correlation coef-
ficient in urea concentration was observed between pregnant and lambed ewes (r = -
0.14, p<0.05). There were also correlations between BHB and glucose concentrations 
in pregnant ewes (r=-0.16, p<0.01), between BHB and cortisol concentrations in 
lambed ewes (r=0.25, p<0.01) and between BHB and urea concentrations in aborted 
ewes (r=0.28, p<0.05). With regard to the references, the concentration of BHB>0.7 
mmol/litre is considered as subclinical pregnancy toxaemia, the distribution and per-
centage of ewes in pregnant, lambed and aborted groups were 61 (12.3%), 17 (7%) 
and 6 (8.57%), respectively. Similarly, for glucose < 20 mg/dl were 76 (15.3%), 38 
(15.7%) and 10 (14.3%) and for cortisol >52 ng/ml were 28 (8.54%), 1 (0.6) and 5 
(10.2%), respectively. Significant differences were found for BHB and cortisol groups. 
The highest subclinical pregnancy toxaemia occurs among pregnant and aborted ewes. 
Mean comparison of parameters in the group with BHB > 0.7 mmol/litre showed a 
significant difference (p<0.01) for urea and cortisol concentrations and in the group 
with glucose < 20 mg/dl and cortisol >52 ng/ml showed differences just for BHB con-
centration. Thus, it is concluded that hypoglycaemia, uraemia and high cortisol con-
 20
centration in late pregnancy could be considered as subclinical pregnancy toxaemia up 
to 12% that should be seriously considered in order for prevention or treatment. 
 
MOGHADDAM and HASSANPOUR (2008) studied 134 ewes in the Tabriz area of 
Iran. The levels of glucose, BHB, blood urea nitrogen (BUN) and calcium were meas-
ured by spectrophotometry. The mean level of BHB in the prepartum period was sig-
nificantly higher than in the postpartum period (p<0.05). The mean level of glucose in 
the prepartum period was significantly lower than the postpartum period (p<0.05). 
There were negative and significant correlations between BHB and glucose levels both 
pre- and postpartum periods (r=-0.55, p<0.01 and r=-0.59, p<0.01, respectively). The 
level of BUN in the prepartum period was greater than the postpartum period but was 
not significantly different. The level of calcium in the prepartum period was signifi-
cantly higher than in the postpartum period (p<0.01), but there was no significant cor-
relation between glucose and calcium levels in either periods. 20 ewes (14.9%, 
p<0.05) suffered from subclinical pregnancy toxaemia, as indicated by a BHB concen-
tration more than 0.7 mmol/litre. In conclusion, hypoglycaemia, uraemia and hyperke-
tonaemia in late pregnancy could be considered as subclinical pregnancy toxaemia. 
 
2.3.4 Free fatty acids 
SYMONDS et al. (1989) determined how the long-term metabolic adaptations to win-
ter shearing of the pregnant ewe result in significant changes in the rates of lipid mobi-
lization and utilization of FFA in comparison with unshorn controls. Continuous infu-
sions of [1-14C]palmitic acid, [2-3H]glycerol and NaH14CO3 were used to measure 
whole-body lipid metabolism in fed (estimated metabolizable energy (ME) intake 9.54 
MJ/d) and under-fed (estimated ME intake of 3 MJ/d), shorn and unshorn sheep over 
the final four weeks of pregnancy. Whole-body carbon dioxide, estimated heat produc-
tion, total FFA entry and oxidation rates were all significantly higher in fed shorn ewes 
compared with unshorn controls, even though there was no difference in the arterial 
plasma FFA concentration. These differences may be mediated via an increase in the 
plasma concentrations of thyroid hormones in shorn animals. As a result of under-
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feeding any significant differences in lipid metabolism between shorn and unshorn 
groups were removed. In all sheep the mean total FFA entry rate as measured using [1-
14C] palmitic acid was 3.4 times the value obtained using [2-3H] glycerol. It is con-
cluded that when sheep are fed on a diet from which no more than half the required 
ME for late pregnancy is obtained, and then lipolysis of body fat depots occurs via the 
incomplete breakdown of adipose tissue triglycerides. This effect is significantly 
greater in the fed shorn pregnant ewe which exhibits higher entry and oxidation rates 
of FFA. 
PETTERSON et al (1994) measured Plasma concentrations of FFA and glycerol under 
basal conditions and during infusion of various doses of insulin while maintaining eu-
glycemia (hyperinsulinemic, euglycemic clamp technique). Pregnancy and undernutri-
tion separately increased basal plasma FFA concentration in an additive manner; 
plasma glycerol was increased by pregnancy but unaffected by undernutrition. The 
molar ratio of FFA to glycerol was significantly greater in underfed ewes. Analysis of 
dose-response relations between plasma insulin and metabolites during insulin infu-
sions showed that maximally insulin-suppressed concentrations of FFA and glycerol 
were significantly greater in pregnant than in nonpregnant ewes but were unaffected 
by undernutrition. Neither pregnancy nor undernutrition affected the maximally insu-
lin-suppressed FFA to glycerol ratio, or the plasma insulin concentration for 50% 
maximal responses to insulin of plasma FFA, plasma glycerol, or the plasma FFA to 
glycerol ratio. Thus, even in ewes at or close to zero energy balance, pregnancy seems 
to reduce adipose responsiveness but not sensitivity to the antilipolytic effect of insu-
lin. This is another manifestation of the normal development of insulin resistance in 
maternal tissues during late pregnancy. 
 
REGNAULT et al. (2004) designed experiments to examine if the pregnancy-
associated rise in FFA concentration is associated with a reduced pancreatic sensitivity 
to glucose in vivo. they investigated the possible relationship of FFA concentrations in 
regulating maternal insulin concentrations during ovine pregnancy at three physiologi-
cal states, non-pregnant, non-lactating (NPNL),and at 105 and 135 days gestational 
age (DGA, term 147±3 days).The plasma concentrations of insulin, growth hormone 
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(GH) and ovine placental lactogen (OPL) were determined by double antibody radio-
immunoassay. Insulin responsiveness to glucose was measured using bolus injection 
and hyperglycaemic clamp techniques in 15 non-pregnant, non-lactating ewes and in 
nine pregnant ewes at 105 DGA and near term at 135 DGA. Plasma samples were also 
collected for hormone determination. In addition to bolus injection glucose and insulin 
area under curve calculations, the Mean plasma glucose increment, glucose infusion 
rate and mean plasma insulin increment and area under curve were determined for the 
hyperglycaemic clamp procedures. Statistical analysis of data was conducted with 
Students t-tests, repeated measures ANOVA and 2-way ANOVA. Maternal growth 
hormone, placental lactogen and FFA concentrations increased, while basal glucose 
and insulin concentrations declined with advancing gestation. At 135 DGA following 
bolus glucose injections, peak insulin concentrations and insulin area under curve 
(AUC) profiles were significantly reduced in pregnant ewes compared with NPNL 
control ewes (p<0.001 and p<0.001, respectively). In hyperglycaemic clamp studies, 
while maintaining glucose levels not different from NPNL ewes, pregnant ewes dis-
played significantly reduced insulin responses and a maintained depressed insulin se-
cretion. In NPNL ewes, 105 and 135 dGA ewes, the Glucose infusion rate (GIR) was 
constant at approximately 5.8 mg glucose/kg/min during the last 40 minutes of the hy-
perglycaemic clamp and the Mean Plasma Insulin Increment (MPII) was only signifi-
cantly (p<0.001) greater in NPNL ewes. Following the clamp, FFA concentrations 
were reduced by approximately 60% of pre-clamp levels in all groups, though a 
blunted and suppressed insulin response was maintained in 105 and 135 DGA ewes. 
Results suggest that despite an acute suppression of circulating FFA concentrations 
during pregnancy, the associated steroids and hormones of pregnancy and possibly 
FFA metabolism, may act to maintain a reduced insulin output, thereby sparing glu-
cose for non-insulin dependent placental uptake and ultimately, fetal requirements. 
 
2.4 TNFα and its role in fat metabolism and pregnancy toxaemia 
GREER et al. (1994) determined if plasma concentrations of defined cytokines are 
increased in women with preeclampsia, and to correlate any increases with the ele-
vated concentrations of the vascular cell adhesion molecule (VCAM)-1. Twenty 
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primiparous with preeclampsia were compared to 20 healthy primiparous. Plasma lev-
els of cytokines, TNFα, interleukin (IL)-6, IL-8, IL-1 beta, IL-1 receptor antagonist 
(IL-1ra), granulocyte macrophage-colony-stimulating factor (GM-CSF), and VCAM-
1, were measured by enzyme-linked immunosorbent assay. It is concluded that con-
centrations of IL-6 and IL-1ra were significantly higher (p<0.01) in preeclamptic 
women (2.56 and 251.85 pg/mL, respectively) compared to normal pregnant patients 
(2.06 and 142.00 pg/mL, respectively). There were no significant changes in concen-
trations of TNFα, IL-8, GM-CSF, and IL-1 β in preeclamptic patients (14.09, 50.52, 
125.8, and 2.08 pg/mL, respectively) compared to normal patients (11.96 44.46, 121.3, 
and 2.01 pg/mL, respectively). Serum concentrations of VCAM-1 were increased in 
women with preeclampsia (preeclamptic group 841.9±49.7 ng/mL, control group 
560.2±47.9 ng/mL; t=3.673, p<0.001). Interleukin-6 and IL-1ra concentrations correla-
ted with VCAM-1 concentrations (IL-6: r=0.539, z = 2.9, p<0.005; IL-1ra: r=0.451, z 
= 2.428, p<0.02). In conclusion, increased cytokine concentrations may contribute to 
the endothelial damage that occurs with preeclampsia and may explain the mechanism 
underlying leukocyte activation in this disorder. The increased cytokine concentration 
may also be responsible for the endothelial adhesion that accompanies preeclampsia. 
KUPFERMINC (1994) investigated whether markers for activation of the immune 
system are present in patients with preeclampsia by assessing maternal plasma and 
amniotic fluid for TNFα and IL-1 β. Twenty-one patients with severe preeclampsia 
composed the study group (group A). An ante partum comparison group was com-
posed of healthy nulliparous patients not in labour and matched for gestational age 
(group B). Another control group consisted of term nulliparous patients in labour with 
uneventful pregnancies (group C). Maternal plasma samples were collected from all 
patients at recruitment and from patients in groups A and C immediately after delivery 
and again 20 to 24 hours post partum. Amniotic fluid was also collected from patients 
in groups A and C during labour. All samples were collectively assayed for tumor ne-
crosis factor-alpha and interleukin-1 beta by specific enzyme-linked immunoassays. 
Before labour tumor necrosis factor-alpha was detected more frequently in the plasma 
of preeclamptic patients than in the plasma of patients in group B (12/16 vs 5/16, 
p<0.05) and in higher concentrations (median 35 pg/ml, p<0.05). Although tumor ne-
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crosis factor-alpha was frequently detected in the plasma of patients in group C in 
early labour (16/20) concentrations were higher in the four preeclamptic patients first 
sampled in early labour (210 pg/ml vs 65 pg/ml, p<0.05). Similarly, amniotic fluid 
levels of tumor necrosis factor-alpha were increased in preeclamptic patients compared 
with control patients. At delivery tumor necrosis factor-alpha was more likely to be 
identified in the plasma of preeclamptic patients and was found in higher concentra-
tions, but by 20 to 24 hours post partum measurements in the preeclamptic and control 
patients were similar. There were no differences in the frequency with which IL-1 β 
was detected or the concentration of IL-1 β in any of the samples. It is concluded that 
TNFα is increased in the plasma and amniotic fluid of patients with severe preeclamp-
sia. These data are suggestive of a role for abnormal immune activation in the patho-
physiological mechanisms of preeclampsia. 
SEOW et al. (1995) cloned ovine tumour necrosis factor-alpha (OvTNFα) by reverse 
transcription-polymerase reaction using RNA isolated from lipopolysaccharide (LPS)-
stimulated alveolar macrophages and primers based on the human TNFα cDNA se-
quence. An expression vector which carries the coding sequence of the mature form of 
ovine TNF was constructed. rOvTNFα was expressed as a glutathione-S-transferase 
(GST) fusion protein. It was cleaved with thrombin to yield rOvTNF free of the GST 
moiety. Growth at a lower temperature of 30ºC and use of Escherichia coli strains 
AM207, AM305, E392 and NM522 did not improve the recovery of rOvTNFα from 
the soluble fraction to a significant extent. Purification of recombinant proteins was 
achieved rapidly and easily by affinity chromatography using glutathione-Sepharose. 
Yields of pure rOvTNFα achieved in E. coli JM109 and AM207 were approximately 1 
mg/litre. Both rOvTNFα and rhTNFα exerted cytotoxicity on L929 cells. However, 
rOvTNF- alpha but not rhTNF- alpha stimulated proliferation of ovine thymocytes. 
Maximum levels of TNFα mRNA expression by LPS-stimulated ovine alveolar 
macrophages were detected at approximately four hours after stimulation. 
VINCE et al. (1995) investigated TNFα may play an important role in pre-eclampsia 
and contribute to endothelial activation. Plasma TNFα, IL-6 and both forms of soluble 
TNF receptors (p55 and p75 TNF-R) have been measured by ELISA in 31 pre-
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eclamptic patients and 31 pregnant controls matched for age, parity and gestational 
age. Levels of IL-6, TNF-alpha and soluble TNF-R (p55 and p75) were significantly 
higher in pre-eclamptic patients, compared with age and gestation matched controls 
with a wide variation in levels between pre-eclamptic individuals. There was a correla-
tion between levels of IL-6 and TNF or TNF-R and between TNF and TNF-R levels. 
However, when the pre-eclamptic patients were subdivided on the basis of the severity 
of their disease, the median values of plasma concentrations of IL-6, TNFα and TNF-R 
were all higher in the group with lower platelet counts. It was concluded that these 
new findings were consistent with the concept that the maternal syndrome of pre-
eclampsia is associated with endothelial dysfunction and provide evidence that at least 
part of this dysfunction could arise from excessive release of TNFα into the circula-
tion. 
BENYO et al. (1997) investigated TNFα and interleukin-1 (IL-1) are inflammatory 
cytokines capable of eliciting endothelial cell dysfunction, whether the production of 
these inflammatory cytokines by cultured villous explants from the human placenta 
was affected by incubation in reduced oxygen (2% O2). The term placenta produced 
TNFα, IL-6, and low levels of IL-1α and IL-1ß under standard tissue culture condi-
tions. Hypoxia significantly increased TNFα, IL-1α, and IL-1ß production by 2-, 6-, 
and 23-fold, respectively, but did not affect IL-6 production. Further, cytokines were 
immunolocalized to the syncytiotrophoblast layer as well as to some villous core cells. 
Hypoxic regulation of placental TNFα and IL-1ß production also appeared to differ 
based on gestational age. Finally, treatment with either cobalt chloride or an iron chela-
tor mimicked the hypoxic response, suggesting that stimulation of placental cytokine 
production may involve a heme-containing, O2-sensing protein. These results suggest 
that placental hypoxia can lead to the elaboration of inflammatory cytokines, which 
may contribute to the pathophysiology of preeclampsia. 
CONRAD et al. (1997) explored the hypothesis that TNFα and possibly other inflam-
matory cytokines are overproduced by the placenta in response to local ische-
mia/hypoxia contributing to increased plasma levels, and subsequent endothelial acti-
vation and dysfunction in the pregnancy disorder, preeclampsia. It is widely held that 
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inadequate trophoblast invasion and physiologic remodeling of spiral arteries initiate 
placental ischemia/hypoxia in preeclampsia. Furthermore, focal areas of placental hy-
poxia have been implicated in the production of "toxic" factor by the placenta, which 
circulate and cause maternal disease. Placental trophoblast cells and fetoplacental 
macrophages normally produce TNFα and interleukin-1 (IL-1), which are capable of 
producing endothelial cell activation and dysfunction. Hypoxia has recently been re-
ported to increase TNFα and IL-1 production by term villous explants from the human 
placenta. Placental cells also express erythropoietin (EPO), which is the prototype 
molecule for transcriptional regulation by hypoxia in mammals. Interestingly, TNFα 
and IL-1 have DNA sequence homologous or nearly homologous to the hypoxia-
responsive enhancer element of the EPO gene, thus providing a potential, but as of yet, 
untested molecular link between placental hypoxia and stimulation of cytokine produc-
tion. Inflammatory cytokines overproduced by the placenta in response to hypoxia 
may then lead to increased plasma levels and endothelial activation and dysfunction in 
preeclampsia. The purpose of this short review is to critically evaluate the hypothesis 
that placental cytokines contribute to the pathogenesis of preeclampsia. Off note, the 
etiology of the disease presumably related to deficient trophoblast invasion is beyond 
the scope of this work. 
CONRAD et al. (1998) measured plasma levels of immunoreactive  TNFα and -β, in-
terleukin (IL)-1 α  and -β, and IL-6 and -10 in women with preeclampsia, in women 
with transient gestational hypertension, and throughout normal pregnancy. Enzyme-
linked immunosorbent assays were used and subjected to extensive validation studies. 
The median concentration of plasma TNFα was increased two fold in women with 
preeclampsia compared with that in normal third-trimester pregnancy (p<0.001) and in 
women with gestational hypertension (p<0.04). The median concentration of plasma 
IL-6 was increased by threefold in women with preeclampsia compared with that in 
normal third-trimester pregnancy (p<0.001) and increased twofold compared with that 
in women with gestational hypertension (p<0.1). There were no significant differences 
observed in the levels of plasma IL-1 β and IL-10 between the preeclamptic and other 
subject groups. The level of IL-1 β, but not the levels of IL-10, TNFα, or IL-6, was 
significantly changed during normal pregnancy compared with the nonpregnant condi-
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tion manifesting an overall decline (p<0.04). TNFα and IL-1 were not detected in any 
samples, possibly because of the low sensitivity of these particular immunoassays. It 
was concluded that elevated levels TNFα and IL-6 may contribute to the putative en-
dothelial dysfunction of preeclampsia. 
GASIC et al. (1998) investigated the hypothesis that TNFα stimulates lipolysis by 
blocking the action of endogenous adenosine. Adipocytes were incubated for 48 hours 
with TNFα, and lipolysis was measured in the absence and presence of adenosine 
deaminase. Without adenosine deaminase, the rate of glycerol release was two-three 
times higher in the TNFα-treated cells, but with adenosine deaminase lipolysis 
increased in the control cells to approximately that in the TNFα-treated cells. This 
suggests that TNFα blocks adenosine release, or prevents its antilipolytic effect. Both 
N6-phenylisopropyl adenosine and nicotinic acid were less potent and efficacious 
inhibitors of lipolysis in treated cells. A decrease in the concentration of α-subunits of 
all three Gi subtypes was detected by western blotting without a change in Gsproteins 
or β-subunits. Gi2α was about 50% of control, whereas Gi1α and Gi3α were about 20% 
and 40% of control values, respectively. The time course of Gidown-regulation 
correlated with the stimulation of lipolysis. Furthermore, down-regulation of Gi by an 
alternative approach (prolonged incubation with N6-phenylisopropyl adenosine) 
stimulated lipolysis. These findings indicate that TNFα stimulates lipolysis by blunting 
endogenous inhibition of lipolysis. The mechanism appears to be a Gi protein down-
regulation.  
 
JOHNSON et al. (1999) studied the hypothesis that TNFα secreted from the oocyte-
cumulus cell complex stimulates follicular collagenase secretion and thereby contrib-
utes to ovarian wall degradation and ovulatory rupture. Pro-oestrous ewes were treated 
with GnRH-agonist (5 µg i.m. des Gly10-Ala6 ethylamide) to synchronize the onset of 
the gonadotropin surge; ovulation occurred approximately 24 hours later. There was an 
increase in TNFα (immunoassay) in antral fluid of preovulatory follicles at 18 hours 
after GnRH injection, which was related to tissue collagenolytic bioactivity (radio-
labelled type 1 substrate digestion by enzymatic extract) and collagen (hy-
droxyproline) depletion. Intrafollicular injection of TNFα antibodies at 12 hours after 
 28
GnRH injection negated the rise in follicular collagenolytic bioactivity (and is known 
to block ovulation in the sheep). Collagenase secretion was enhanced when follicular 
tissues (0-h GnRH) were incubated (6 hours) with recombinant TNFα; this effect was 
inhibited by the transcriptional inhibitor actinomycin D. Secretion of TNFα by oocyte-
cumulus cell complexes isolated from preovulatory follicles simulated the in vivo cir-
cumstance. Immunostaining indicated that TNFα was confined mainly to the oocyte 
before GnRH administration, accumulated in cumulus cells during the mid-to-late pre-
ovulatory period, and was expended with the imminent approach of ovulation. It is 
concluded that oocyte-cumulus cell complex is a source of soluble TNFα. This is 
thought to be the first study to show that up regulation of collagenase expression as a 
target mode of TNFα action in preovulatory follicles. 
MOLDES et al. (2001) identified novel genes and proteins that could mediate the 
effects of TNFα on adipocyte metabolism and development, the authors have used a 
differential display technique comparing 3T3-L1 cells exposed or not to the cytokine. 
They have isolated a novel adipose cDNA encoding a TNFα-inducible 470-amino acid 
protein termed TIARP, with six putative transmembrane regions flanked by a large 
amino-terminal and a short carboxyl-terminal domain, a structure reminiscent of 
channel and transporter proteins. Commitment into the differentiation process is 
required for cytokine responsiveness. The differentiation process per se is 
accompanied by a sharp emergence of TIARP mRNA transcripts, in parallel with the 
expression of the protein at the plasma membrane. Transcripts are present at high 
levels in white and brown adipose tissues, and are also detectable in liver, kidney, 
heart, and skeletal muscle. Whereas the biological function of TIARP is presently 
unknown, its pattern of expression during adipose conversion and in response to TNFα 
exposure as a transmembrane protein mainly located at the cell surface suggest that 
TIARP might participate in adipocyte development, and metabolism and mediate some 
TNFα effects on the fat cell as a channel or transporter. 
BENYO et al. (2001) compared TNFα, IL-1α, IL-1β, and IL-6 levels in placentas from 
patients with preeclampsia and normal term pregnancies. Because the placenta is a 
large heterogeneous organ, the authors analyzed multiple sites per placenta. On aver-
age, there was a three fold variation in cytokine protein levels across the eight sites 
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analyzed for each placenta. However, there were no significant overall differences 
among the normal term, preeclamptic, and preterm placentas from women without 
preeclampsia. There were also no significant differences in TNFα messenger ribonu-
cleic acid between the normal term and preeclamptic placentas, although TNFα mes-
senger ribonucleic acid levels were lower in placentas from preterm patients without 
diagnosis of preeclampsia than in the normal term placentas. In vitro, hypoxia stimu-
lated the production of TNFα, IL-1α and IL-1β, but not that of IL-6, by placental vil-
lous explants from both groups of patients, and this was not exaggerated in preeclamp-
sia. Finally, although peripheral and uterine venous levels of TNFα were elevated in 
preeclamptic women compared with normal term patients, the ratio of uterine to pe-
ripheral venous TNFα levels were not significantly different from 1.0 for either patient 
group. Taken together, these results suggest that sources other than the placenta con-
tribute to the elevated concentrations of TNFα and IL-6 found in the circulation of 
preeclamptic women. 
GONZALEZ et al. (2001) designed a multicenter prospective clinical study with the 
purpose of measuring TNFα and TNFα-receptors p55 and p75 (sTNFα-p55 and 
sTNFα-p75) in normal pregnancy and preeclampsia (PE). Blood samples were col-
lected without anticoagulant from 30 pregnant women, matched for chronological and 
gestational age, 15 healthy pregnant (group A) and 15 women with PE (group B). 
TNFα was measured by enzyme linked immunosorbent assay and sTNFα-p55 and 
sTNFα-p75 were measured by amplified immuno enzymo metric assay. The statistical 
analysis was carried out using the paired t student test. The values of TNFα were 
7.07±1.63 pg/mL (mean±SD) in group A and 16.43±2.92 in group B pg/mL 
(p<0.05).); concentrations of sTNFα-p55 were 2.69±0.17 ng/mL and 5.18±0.54 ng/mL 
in groups A and B respectively (p<0.001); sTNFα-p75 reached levels of 5.94±0.27 
ng/mL in healthy pregnant and 9.02±0.66 ng/mL in patients with PE (p<0.001). TNFα, 
sTNFα-p55 and sTNFα-p75 were significantly higher in preeclamptic women than in 
normotensive controls. These findings indicate that the levels of TNFα, TNFα-p55 and 
TNFα-p75 were elevated in PE. Further research is needed to identify modifiable risk 
factors for the excessive synthesis and release of TNFα in pregnancy, and to assess 
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whether the lowering of TNFα concentrations in pregnancy alters the incidence and 
severity of PE. 
COLDITZ (2002) mentioned that the immune system provides host defense by sensing 
non-self molecules that herald a threat from foreign organisms. A level of stimulation 
of this sense organ is necessary for health of the host. Following excessive stimulation, 
as may occur during disease challenge or exposure to a high microbial burden in an 
unhygienic environment, outputs of the immune system affect homeostatic pathways 
that regulate metabolism, nutrient partitioning, behaviour, thermoregulation and hypo-
thalamic-pituitary-adrenocortical (HPA) activity. Important consequences of excessive 
immune activation include production of the pro-inflammatory cytokines IL-1β, IL-6, 
TNFα and IFNα/β , activation of the acute phase response, fever, inappetence, amino 
acid resorption from muscle, redirection of nutrients from accretion in meat, milk and 
wool towards liver anabolism of acute phase proteins, and stimulation of leptin pro-
duction. Thus immunological resistance to disease in livestock may incur a production 
cost due to redirection of nutrients away from production tissues. Counter-balancing 
the cost of resistance is the metabolic cost of disease. The metabolic costs of resistance 
to internal parasites in sheep are considered. Genetic variation in the cost of disease 
resistance could occur due to (1) variation in sensitivity to input stimuli that trigger 
immune responses or (2) variation in the quantity or type of output signals generated 
following immune stimulation. Downstream sensitivity of tissues to outputs of the 
immune system could also differ. The ideal product to monitor the burden imposed on 
metabolic pathways by activity of the immune system would be unique to innate and 
acquired immune responses. Acute phase proteins and pro-inflammatory cytokines 
have attracted attention in this respect; however, non-immunological stimuli such as 
tissue injury and psychosocial stressors can also induce these products that are usually 
associated with the immune system. Immuno nutritional and therapeutic strategies to 
limit the production costs of excessive activation of the immune system are considered 
RYDEN et al. (2002) recorded that TNFα is a pleiotropic cytokine with a proposed 
role in obesity-related insulin resistance. This could be mediated by increased lipolysis 
in adipose tissue resulting in elevated free fatty acid levels. The early intracellular 
signals entailed in TNFα-mediated lipolysis are unknown but may involve members of 
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the mitogen-activated protein kinase (MAPK) family. The authors investigated the 
possible contribution of MAPK in TNFα-induced lipolysis in human preadipocytes. 
TNFα activated the three mammalian MAPK, p44/42, JNK, and p38, in a distinct 
time- and concentration-dependent manner. TNFα also induced a concentration-
dependent stimulation of lipolysis with a more than three fold increase at the maximal 
dose. Lipolysis was completely inhibited by blockers specific for p44/42 (PD98059) 
and JNK (dimetylaminopurine) but was not affected by the p38 blocker SB203580. 
Use of receptor-specific TNFα mutants showed that activation of MAPK is entirely 
mediated by the TNFR1 receptor. The results in human preadipocytes differed from 
those obtained in murine 3T3-L1 adipocytes in which all three MAPK were 
constitutively active. Thus, studies of intracellular signaling pathways obtained in 
different cellular contents should be interpreted with caution according to the authors. 
In conclusion, although TNFα activates all three known MAPK in human 
preadipocytes, only p44/42 and JNK appear to be involved in the regulation of 
lipolysis. 
ZHANG et al. (2002) demonstrate that TNFα increases lipolysis in differentiated 
human adipocytes by activation of mitogen-activated protein kinase (MAPK), 
extracellular signal-related kinase (ERK), and elevation of intracellular cAMP. TNFα 
activated ERK and increased lipolysis; these effects were inhibited by two specific 
MAPK inhibitors, PD98059 and U0126. TNFα treatment caused an electrophoretic 
shift of perilipin from 65 to 67 kDa, consistent with perilipin hyperphosphorylation by 
activated cAMP-dependent protein kinase A (PKA). Coincubation with TNFα and 
MAPK inhibitors caused perilipin to migrate as a single 65-kDa band. Consistent with 
the hypothesis that TNFα induces perilipin hyperphosphorylation by activating PKA, 
TNFα increased intracellular cAMP ∼1.7-fold, and the increase was abrogated by 
PD98059. Furthermore, H89, a specific PKA inhibitor, blocked TNF-α-induced 
lipolysis and the electrophoretic shift of perilipin, suggesting a role for PKA in TNFα-
induced lipolysis. Finally, TNFα decreased the expression of cyclic-nucleotide 
phosphodiesterase 3B (PDE3B) by ∼50%, delineating a mechanism by which TNFα 
could increase intracellular cAMP. Cotreatment with PD98059 restored PDE3B 
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expression. These studies suggest that in human adipocytes, TNFα stimulates lipolysis 
through activation of MAPK-ERK and subsequent increase in intracellular cAMP. 
DANIEL et al. (2003) designed four studies to determine whether the following: (1) 
TNFα and the Lipopolysaccharide (LPS) binding ligand, CD14, are produced by sheep 
adipose tissue; (2) nutritional reserves and/or short-term fasting affect circulating con-
centrations of TNF; (3) there is a relationship between TNF and metabolic factors in 
sheep; and (4) inflammation alters circulating concentrations of leptin. Ewes were as-
signed in experiments one and two, based on ultrasonic assessments of last-rib subcu-
taneous fat measurements to fat (fat thickness >1 cm; mean=1.52±0.03 cm) or thin (fat 
thickness < 1 cm; mean = 0.25±0.03 cm) groups. Fat and thin ewes were assigned to 
fed or fasted groups for a total of four groups (fed-fat, fasted-fat, fed-thin, fasted-thin). 
Fed ewes had ad libitum access to feed, and fasted-ewes were prohibited feed 48 hours 
before initiation of sample collection. In Experiment one, subcutaneous fat samples 
were collected from just above the last rib for detection of TNFα and CD14 mRNA, 
and immunoreactivity. TNFα -like immunoreactivity in adipocytes was sparse and 
more pronounced in cells in fed-ewes than fasted-ewes, and localized to membranes 
between adjacent cells in nucleated regions. Immunoreactivity for CD14 was mini-
mally observed but present in adipocytes and widely expressed in infiltrating mono-
cytes and epithelial vascular cells. Leptin was detected in adipocytes. In Exp. two, 
plasma samples collected every six hours for 24 hours were analyzed for plasma con-
centrations of TNFα. Fat ewes had greater plasma concentrations of TNFα than thin 
ewes (p= 0.039). In Experiment three ewes were injected intravenous with interleukin-
1β or TNFα. Blood samples were collected every 15 minutes for eight hours following 
injection. Plasma concentration of leptin was not affected by treatment (p> 0.39). In 
Experiment four ewes were injected intavenous with interleukin-1beta or TNF. Blood 
samples were collected every 15 minutes for eight hours following injection. Plasma 
concentration of leptin was not altered by LPS (p>0.20). The following results provide 
evidence: (1) of TNF-like immunoreactivity within fat tissue; (2) that elements within 
fatty tissues have CD14 that may allow adipocyte function to be directly affected by 
LPS; (3) that plasma concentrations of leptin are not altered by LPS treatment; and 
lastly (4) that circulating concentrations of TNFα are elevated with obesity in sheep. 
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RAHMAN et al. (2004) examined the expression of key cytokines and vascular sur-
face molecules in the uterus of pregnant sheep around the time of implantation. Uter-
ine tissues and uterine washings were collected from non-pregnant and pregnant sheep 
at 17-19 days post-coitus (dpc), 26-27 and 34-36 dpc. Reverse transcriptase-
polymerase chain reaction (RT-PCR) analysis of caruncular/placentomal tissues re-
vealed that cytokines IL-2, IL-4 and IL-8, which were not detected in non-pregnant 
uteri, were induced more strongly at 26-27 dpc than in other stages of pregnancy 
tested. Cytokines LIF, IL-6, IL-10, TNFα were also most highly expressed at 26-27 
dpc, expression of them being lower at other time-points during early pregnancy and 
non-pregnancy. The cytokines IL-1 beta, IFN- gamma and TGF- beta were expressed 
in all non-pregnant and pregnant tissues examined. Enzyme-linked immunosorbent 
assay (ELISA) performed on uterine washings clearly detected the presence of IL-1α 
protein at 26-27 and 34-36 dpc. Immuno histochemistry revealed that expression of 
vascular adhesion molecule VCAM-1 in endometrial endothelium was strongly in-
duced at 26-27 dpc in the pregnant endometrium. Expression of CD5 on vascular en-
dothelium was not induced in placentomal tissues until 26-27 dpc and was further in-
creased by 34-36 dpc. These results demonstrate a dynamic change in a wide range of 
cytokines during early stages of pregnancy, with a critical period around 26-27 dpc. In 
addition, at 26-27 dpc, expression of the surface/adhesion molecules, CD5 and 
VCAM-1, is induced on vascular endothelium of the sheep endometrium, possibly as a 
direct consequence of the changed cytokine environment, and may be involved in di-
recting the changes in leukocyte migration observed during pregnancy. 
 
JIANG et al. (2004) examined 13 healthy pregnant and five non-pregnant ewes (con-
trol) after 15-40 days of parturition. The contents of IL-1β, IL-6 and TNFα were 
measured at 85, 105, 125 and 140 days after gestation and 150 days of parturition, us-
ing the liquid phase competition and equilibrium methods. The contents of serum IL-β 
and IL-6 at 125 day after gestation were significantly higher than those in non-
pregnant sheep (control), and the contents of serum TNFα in the mid and late stages of 
pregnancy were also higher than in the control. During pregnancy, the level of three 
cytokines in serum increased gradually and reached its peak at 125 days. They then 
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subsequently decreased, and rose again at parturition, but still remained lower than the 
maximum at 125 days. It is suggested that there is a close relationship between cyto-
kines and gestation, which play an important role in maintaining gestation. TNF 
probably played an important role in parturition, while IL-1β and IL-6 showed no ef-
fect. 
GREEN et al. (2004) studied that both TNFα and hyperglycemia impair insulin 
sensitivity in vivo. This may be secondary to stimulation of adipose tissue lipolysis 
and consequent increased circulating FFA. Here we report that neither TNFα nor 
glucose alone has a pronounced effect on lipolysis in 3T3-L1 adipocytes. However, the 
combination of TNFα plus glucose markedly stimulates lipolysis. Glucose does not 
affect the ability of isoproterenol to stimulate lipolysis. Alternative substrates such as 
acetate, pyruvate, and lactate do not allow the TNFα effect. Mannose was almost as 
effective as glucose; fructose was marginally effective, but galactose was ineffective. 
The effectiveness of the sugars corresponded with production of lactate, it means that 
the cells readily produced lactate from glucose or mannose, slightly from fructose, and 
not at all from galactose. The ability of TNFα to phosphorylate extracellular signal-
regulated kinase 1 (ERK1) and ERK2 and to downregulate perilipin (which has been 
implicated in the lipolytic effect of TNFα) was not affected by glucose. It is concluded 
that the lipolytic action of TNFα is influenced by glucose in 3T3-L1 adipocytes. The 
findings suggest that glucose metabolism is required for the lipolytic response to 
TNFα but not for early signaling events. These findings suggest novel mechanisms by 
which TNFα and hyperglycemia raise FFA levels and induce insulin resistance. 
HUNG et al. (2004) demonstrated that hypoxia-reoxygenation (H/R) of placental tis-
sues in vitro causes equivalent oxidative stress to that seen in preeclampsia. The aim 
was to determine whether H/R also increases production of TNFα, and whether condi-
tioned media from samples exposed to H/R causes activation of human umbilical vein 
endothelial cells (HUVECs). Concentrations of mRNA encoding TNFα were signifi-
cantly higher in placental tissues subjected to H/R compared to hypoxic or normoxic 
controls. Although there was no difference in the concentrations of TNFα protein in 
tissue homogenates, levels of TNFα protein in the medium were significantly higher 
after H/R compared to controls, indicating increased secretion. Furthermore, condi-
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tioned medium from samples subjected to H/R caused increased expression of E-
selectin by HUVECs, and the addition of anti-TNFα antibodies significantly reduced 
that activation. These results are consistent with the hypothesis that intermittent perfu-
sion of the placenta, secondary to reduced trophoblast invasion, causes increased se-
cretion of TNFα, and that this contributes to the activation of maternal endothelial 
cells that characterizes preeclampsia. 
YARIM et al. (2007) determined plasma IL-1β, TNFα and MCP-1 concentrations in 
ewes with severe (n=6) and mild (n=4) naturally occurring pregnancy toxaemia and in 
uncomplicated pregnant ewes (n=10) using enzyme-linked immunosorbent assay 
(ELISA). All ewes with pregnancy toxaemia had significantly lower body temperature 
and respiratory rate than uncomplicated pregnant ewes (p<0.05). With the highest 
concentrations in severe cases, heart rate, proteinuria and serum uric acid levels as 
well as plasma IL-1β, TNFα and MCP-1 were significantly different among all three 
groups (p<0.05). The plasma concentrations of IL-1β in control ewes and ewes with 
mild and severe toxaemia were 15.81±3.90 pg/ml, 23.83±2.42 pg/ml and 34.55±8.03 
pg/ml, respectively. The plasma concentrations of TNFα in control ewes and ewes 
with mild and severe toxaemia were 7.71±0.61 pg/ml, 16.13±3.63 pg/ml, and 
22.85±3.64 pg/ml, respectively. The plasma concentrations of MCP-1 in control ewes 
and ewes with mild and severe toxaemia were 101.70±9.86 pg/ml, 134.75±6.24 pg/ml, 
and 157.67±9.69 pg/ml, respectively. Moreover, plasma IL-1β, TNFα and MCP-1 lev-
els were positively correlated with clinical and well-establish biochemical parameters 
of pregnancy toxaemia, serum uric acid and proteinuria (p<0.01). Concomitant in-
crease of plasma IL-1β, TNFα and MCP-1 concentrations along with serum uric acid, 
proteinuria, and worsening of the clinical signs indicates that such cytokines are in-
volved in the aetiopathogenesis and in perpetuation of the local and systemic inflam-
matory reactions in pregnancy toxaemia in ewes. Hence plasma IL-1β, TNFα and 
MCP-1 may potentially serve as markers to monitor prognosis of pregnancy toxaemia 
in ewes. 
PLOMGAARD et al. (2008) hypothesized that an acute elevation of TNFα in plasma 
would cause an increase in lipolysis, therefore increasing circulatory free fatty acid 
(FFA) levels. Using a randomized controlled, crossover design, healthy young male 
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individuals (n=10) received recombinant human (rh) TNFα (700 ng/m–2·h–1) for four 
hours, and energy metabolism was evaluated using a combination of tracer dilution 
methodology and arterial-venous differences over the leg. Plasma TNFα levels in-
creased from 0.7±0.04 to 16.7±1.8 pg/ml, and plasma IL-6 increased from 1.0±0.2 to 
9.2±1.0 pg/ml (p< 0.05) after four hours rhTNFα infusion. Here, we demonstrate that 
four hours rhTNFα infusion increases whole body lipolysis by 40% (p< 0.05) with a 
concomitant increase in FFA clearance, with no changes in skeletal muscle FFA up-
take, release, or oxidation. Off note, systemic glucose turnover and lactate and cate-
cholamine levels were unaffected by rhTNFα infusion. This study demonstrates that a 
relatively low dose of rhTNFα induces systemic lipolysis and that the skeletal muscle 
fat metabolism is unaffected. 
LEWIS et al. (2009) studied that maternal cytokine levels of TNFα, interleukin (IL)-6, 
IL-8, and IL-10 were varied in women with pre-eclampsia (PE) compared to those 
from normal pregnancies. In this study, the authors determined whether these cytokine 
levels are correlated before and after delivery in patients with PE. Method of study: 
venous blood was obtained from 50 women diagnosed with severe PE at the time of 
admission and 24 hours after delivery. Plasma concentrations for TNFα, IL-6, IL-8, 
and IL-10 were measured by ELISA. Results: there were no statistical differences for 
maternal levels of TNFα, IL-6, IL-8, and IL-10 before and 24 hours postpartum. TNFα 
and IL-10, but not IL-6 and IL-8, levels were significantly correlated before and 24 hr 
after delivery: TNFα: y = 19.963 + 0.953*x; r (2) = 0.924; IL-10: y = 10.521 + 
1.113*x; r(2) = 0.984, P<0.001, respectively. Furthermore, TNFα levels were corre-
lated with IL-10 levels, but not with IL-6 and IL-8 levels. In Conclusion the correla-
tion patterns of TNFα with IL-10 and TNFα with IL-6 and IL-8 suggest disparity in 
functional regulations between these cytokines in maternal circulation in PE. 
ZHU et al. (2010) mentioned that the placenta is a source of cytokines which can in-
duce maternal gestational insulin resistance and alter nutrient transport to the fetus. 
Obesity induces placental inflammation at term, but the impact of obesity on placental 
inflammation earlier in pregnancy has not been defined. Using sheep as an experimen-
tal model, the authors hypothesized that maternal obesity (MO) would induce inflam-
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mation in the cotyledonary (COT) tissue of the placentome by mid-gestation. Non-
pregnant ewes were randomly assigned to a control (C, 100% of NRC recommenda-
tions) or obese (OB, 150% of NRC) group from 60 days before conception to 75 day 
of gestation (dG), when ewes were necropsied and placental COT tissue collected for 
analyses. Free fatty acids content, triglyceride and cholesterol content were higher 
(p<0.05) in the fetal plasma of OB compared to C ewes on day 75. MO increased 
mRNA levels of toll-like receptor (TLR) 2 (p<0.05) and TLR4 (p = 0.06), macrophage 
markers cluster of differentiation (CD)11b (P=0.06), CD14 and CD68 (P<0.05), and 
proinflammatory TNFα (p<0.01), interleukin (IL)-6 (p<0.05), IL-8 (p<0.01) and IL-18 
(p = 0.06), in COT tissue. Inflammatory c-Jun N-terminal kinase (JNK)/c-Jun and nu-
clear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) signaling 
pathways were up-regulated (p<0.05) in COT of OB ewes. In conclusion, MO en-
hanced the placental inflammatory response in OB ewes at mid-gestation, possibly as a 
result of increased TLR4 and free fatty acids. 
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3 Animals, material and methods 
 
3.1 Animals 
Twenty nine pregnant apparently healthy ewes, sixteen from Merino breed and thirteen 
from blackhead breed were housed in Oberholz Farm, Faculty of Veterinary Medicine, 
Leipzig University, Germany. 
Sheep were fed on Wilting Silage in the last five weeks of gestation and then the feed 
was supplemented with whole wheat. 
 
3.2 Clinical examination 
Rectal temperature, heart beat, visible mucous membranes, pulse and respiratory rates 
were examined in all pregnant ewes every time before the blood samples collection. 
The average numbers of lambs were 2.18 and 1.58 /ewe for Merino and Blackhead 
breeds respectively. 
 
3.3 Collection of blood samples 
Blood samples were collected from the jugular veins of 29 pregnant ewes in 5 ml 
Ethylenediaminetetraacetic Acid (EDTA) vacutainer tubes for haematological analysis 
and also into 10 ml plain tubes for serum biochemical analysis. 
The blood samples collection began during the lambing season in January, five weeks 
before parturition and continued according to the following steps. 
• 5 weeks before parturition. 
• 3 weeks before parturition. 
• 1 week before parturition. 
• 4 weeks after parturition 
 
3.4 Analysis of haematological parameters in blood samples 
Packed cell volume (PCV), haemoglobin concentration (HB), Red blood cell count  
(RBCs) and white blood cell count (WBC), mean corpuscular volume (MCV), mean 
corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration 
(MCHC) were estimated by using Hämatologieautomat Advia 120, Fa. Bayer Vital 
GmbH, Fernwald resp. Cellcounter Typ Alvet, Fa. möLAB GmbH, Langenfeld. 
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3.5 Determination of biochemical parameters 
Parameter Method Equipment 
Glucose Hexokinase-Method 
BHB UV-Method 
FFA Kinetic UV-Test 
GLDH UV-Test; optimized standard method of DGKC 
CK NAC-activated, optimized standard method of DGKC 
GGT according to Szast 
Albumin Bromocresol green method 
TP Biuret-Method 
Fe Identification with ferrozine (without deproteinization) 
Cholesterol CHOD-PAP-Method 
 
 
 
 
 
 
 
Hitachi912, 
Testkit Roche  
Diagnostics  
GmbH,  
Mannheim 
Insulin Radioimmunoassay 
Insulin – RIA –Kit,  
IBL Hamburg 
 
3.6 Determination of haptoglobin by using haptoglobin assay 
3.6.1 Haptoglobin assay principle 
Free haemoglobin exhibits peroxidase activity, which is inhibited at low pH. Hap-
toglobin present in the specimen combines with haemoglobin and at low pH preserves 
the peroxidase activity of the bounds haemoglobin (Tridelta kits, Dublin, Ireland). 
Preservation of the peroxidase activity of haemoglobin is directly proportional to the 
amount of haptoglobin present in the specimen. 
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3.6.2 Components 
• Haemoglobin  1*12 ml stabilised Haemoglobin 
• Haemoglobin diluent 1*12 ml haemoglobin diluent 
• Calibrator   1*0.5 ml haptoglobin calibrator (2mg/ml) 
• Chromogen   1*11 ml chromogen reagent 
• Substrate   1*8 ml substrate containing stabilised hydrogen  
peroxides 
• Sample/calibrator diluent 1*12 ml phosphate buffer saline (PBS) 
 
3.6.3 Additional materials required 
• Serum collection equipment 
• Automated analyser (A600 mm) or micro plate reader (A630mm) 
• Accurate micropipettes and disposable tips to deliver 0-10 µl 
• Test tubes and plastic pipettes (5-10 ml) 
• Timer 
• 96 well microtiter plate or strips 
 
3.6.4 Sample and reagent preparation 
3.6.4.1 Samples  
Bloods samples were collected by venipuncture into serum collection tubes and stored 
at -20°C. 
 
3.6.4.2 Haemoglobin  
Accurately premix equal volume of haemoglobin and haemoglobin diluent prior to 
commencement of assay (reagent 1). Prepared reagent was stored at room temperature 
(25°C). 
 
3.6.4.3 Chromogen/Substrate  
Accurately premix chromogen and substrate in a ratio of 9:5 prior to commencement 
of assay (reagent 2). Refer to the following table for suggested volumes. 
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Number of 
Tests 
Volume of 
Chromogen 
Volume of 
Substrate 
10 
20 
40 
8 
0.09 ml 
1.8 ml 
3.6 ml 
7.2 ml 
0.5 ml 
1.0 ml 
2 ml 
4 ml 
 
3.6.5 Manual methods (microplate or spectrophotometric) 
3.6.5.1 Calibrator  
Label five tubes with number C1-C5 corresponding to haptoglobin standards 2, 1, 0.5, 
0.25 and 0 mg/ml respectively. Calibrators for manual test format are prepared by fol-
lowing the steps provided in the table. 
Tube number Volume calibrator Volume diluent Tube concentration 
C1 
C2 
C3 
C4 
C5 
50 µl of stock 
50 µl of stock 
50 µl C2 
50 µl C3 
- 
- 
50 µl 
50 µl 
50 µl 
50 µl 
2.0 mg/ml 
1.0 mg/ml 
0.5 mg/ml 
0.25 mg/ml 
0 mg/ml 
 
Prepared calibrators are stable for 8 hours when stored at room temperature (20-25°C). 
 
3.6.5.2 Test temperature 
The test was performed at 37°C.  
 
3.6.5.3 Procedure 
Note: Addition of diluent haemoglobin (reagent 1) and chromogen/substrate solution 
(reagent 2) was made with a multichannel pipette. 
• Transfer 7.5 µl of each prepared calibrator (0-2mg/ml) -along with test speci-
mens- in duplicate to the blank micro plate. 
• 100 µl of reagent 1 was added to each microwell.  The microplate was shacked 
gently to insure mixing of calibrators specimens and haemoglobin. 
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• 140 µl of reagent 2 was added to each microwell and then incubated for 5 min-
utes at room temperature (20-25°C). 
• Reads immediately at 630 nm. 
• Calibration curve was generated by plotting absorbance (630 nm) versus hap-
toglobin concentration (ng/ml) to facilitate calculation of haptoglobin concen-
tration in test specimens. 
Specimen values were read directly from the curve. Multiply observed value by ap-
propriate factor if specimen dilution was necessary. 
 
3.7 Analysis of cytokine tumor necrosis factor α (TNFα) by using ovine TNFα 
ELISA assay  
 
Protocol of ovine TNFα ELISA assay 
• Each well was filled with 0.5 mg/ml antiovin TNFα (Serotec Nr.AHP 852Z) and 
100 µl concentration 1µg/ml in Carbonat buffer pH 9.0 and incubated overnight 
at 4°C. 
• The plate was washed three times with PBS-T (0.05%) to get rid of excess un-
bound antigen and the remaining free binding sites were blocked by the addition 
of 200µl/well with PBS-T 20 (0.05%) and incubated for one hour at Room tem-
perature. 
• The plate was washed three times with PBS-T (0.05 %). 
• Addition of standard 0-160 ng/ml recombinant ovin TNFα (Serotec PBP005). 
20µg stock solution 100µl/well diluted standard in PBS-T 20 (0.05%), 100 µl 
undiluted 1:10 in PBS-T 20 (0.05%) incubation at room temperature respec-
tively. 
• The plate was washed with PBS-T 0.05%. 
• Secondary Antibody rabbit anti ovin TNFα 0.25 mg (Serotec Nr. AHP 852B). 
100µl was added to all wells (Conc 1µg/ml in PBS 0.05%Tween) and incubated 
for one hour at room temperature. 
• The plate was washed with PBS-T 20 (0.05%). 
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• 100 µl of streptavidin-HRP conjugat (Dianova) was added to all wells (1:5000 in 
PBS-T 20) and incubated for 30 minutes at room temperature. 
• The plate was washed with PBS-T 0.05 %. 
• 100 µl TMB substrate (Pharmingen) was added to all wells (1:1), mixing 5-10 
minute and incubated at room temperature. The reaction was stopped by adding 
100 µl/well of 1 M sulphuric acid. 
• Reading was obtained at optical density 450 nm, reference 620 nm using TNF 
bov/ovin microplate ELISA reader. 
 
3.8 Statistical analysis 
The basis of statistical analysis for the present data was performed according to 
SPss15 software, GmbH Munich. Mann–Whitney test used to determine significant 
differences in all parameters between Black head and Merino sheep and p<0.05 was 
considered statistically significant. 
 
The Bonferroni test is used to determine significant differences in all parameters be-
tween periods of sampling (5 weeks before parturition, 3 weeks before parturition, 1 
week before parturition and 4 weeks after parturition). The mean difference is signifi-
cant at the 0.05 level. 
 
The Pearson correlation test was used to analyse the correlation between TNFα and 
other parameters. p-value <0.05 was considered significant. 
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4 Results 
 
4.1 Clinical examination (observation) 
All sheep showed normal clinical findings (temperature, mucous membrane, and 
pulse) in all periods of sampling. 
 
4.2 Biochemical parameters 
4.2.1 Glucose 
4.2.1.1 Glucose concentrations in all sheep 
The mean values of glucose concentration in 29 pregnant ewes began with high levels 
(4.2 ± 0.86 mmol/l) in the first period of sampling (5 w.b.p.) and then decreased (2.9 ± 
0.73 mmol/l) during the third period of sampling (one week before parturition). It re-
mained at around the same low level (2.8 ± 0.7 mmol/l) in the fourth period of sam-
pling (four weeks after parturition). Figure 1 shows the variation of glucose concentra-
tion at different sampling periods for all sheep. 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 1: Glucose concentrations (mmol/l) in the serum of ewes around parturition 
 
4.2.1.2 Glucose concentrations in Blackhead sheep 
The mean values of glucose concentration began with 3.9 ± 0.79 mmol/l in the first 
sampling period and decreased in the third sampling period to 2.6 ± 0.74 mmol/l. In 
the last period of sampling it began to increase slightly, 2.9 ± 0.74 mmol/l was re-
corded, as seen in Figure 2. 
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4.2.1.3 Glucose concentrations in Merino sheep 
The maximum mean value of glucose concentration was recorded in the first period of 
sampling (4.5 ± 0.86 mmol/l). This value decreased to 3.2 ± 0.66 mmol/l in the third 
sampling period and then to 2.7 ± 0.68 in the last period of sampling, as seen in Figure 
2. 
 
 
 
 
 
 
 
Figure 2: Glucose concentrations (mmol/l) in the serum of Blackhead and Merino 
ewes around parturition 
 
Statistical analysis illustrated that there was significant difference (p<0.05) between 
Blackhead and Merino sheep in the first sampling period while there was no signifi-
cant difference in the other periods of sampling. On the other hand, regarding time of 
sampling, there were significant differences between the periods of sampling one and 
periods, two, three, and four. 
 
 
4.2.2 Insulin 
4.2.2.1 Insulin concentrations in all sheep 
The median values of insulin concentration in period 1 (5 w.b.p.) were 0.13 (0.08, 
0.23) nmol/l (median, first, and third quartiles). Almost the same values were obtained 
in period 2 (3 w.b.p.) and period 3 (1 w.b.p.) recording 0.12 (0.09, 0.21) and 0.12 
(0.09, 0.18) respectively. Then increased in period 4 (4 w.a.p.) to 0.22 (0.18, 0.36) 
nmol/l, as seen in figure 3. 
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Figure 3: Insulin concentrations (nmol/l) in the serum of ewes around parturition 
 
4.2.2.2 Insulin concentrations in Blackhead sheep 
Before parturition, the median value of insulin concentrations were 0.17 (0.1, 0.23); 
0.13 (0.1, 0.3); 0.16 (0.1, 0.26) nmol/l in periods 1, 2, and 3, respectively. After partu-
rition, it increased to 0.25 (0.17, 0.36) nmol/l, as seen in figure 4. 
 
4.2.2.3 Insulin concentrations in Merino sheep 
Before parturition, the median value of insulin concentrations were 0.1 (0.06, 0.23); 
0.11 (0.08, 0.17); and 0.11 (0.08, 0.15) nmol/l in periods 1, 2, and 3, respectively. Af-
ter parturition, it increased to 0.21 (0.18, 0.36) nmol/l in period 4, figure 4.  
   
 
 
 
 
 
 
 
Figure 4: Insulin concentrations (nmol/l) in the serum of Blackhead and Merino ewes 
around parturition 
 
Statistical analysis illustrated that there was a significant difference (p<0.05) between 
the period of sampling four (4 w.a.p.), and the other periods of sampling (before partu-
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rition). On the other hand, there was no significant difference between Blackhead 
sheep and Merino sheep in all periods of sampling. 
 
4.2.3 Free fatty acids 
4.2.3.1 Free fatty acid concentrations in all sheep 
The median values of FFA concentrations showed high levels before parturition. It 
started with 976 (544, 1160) µmol/l (median, first, and third quartiles) and 759 (568.7, 
1313.2) µmol/l in the 1st and 2nd sampling period, respectively, before parturition. It 
then slightly decreased in the 3rd period to 523.5 (387.5, 931.2) µmol/l. After parturi-
tion (in the 4th sampling period), it dropped to 146 (89.5, 272.5) µmol/l, as seen in fig-
ure 5. 
 
 
 
 
 
 
 
 
Figure 5: Free fatty acids concentrations (µmol/l) in the serum of ewes around parturi-
tion 
 
4.2.3.2 Free fatty acid concentrations in Blackhead sheep 
The median values of FFA concentrations were 671 (499.7, 1028) µmol/l and 621.5 
(434.2, 761) µmol/l in the 1st and 2nd sampling periods, respectively. They then de-
creased in the 3rd period to 339 (224.7, 543) µmol/l. After parturition, the concentra-
tion decreased again to 191 (101, 272.5) µmol/l, as shown in figure 6.  
 
4.2.3.3 Free fatty acid concentrations in Merino sheep 
The median values of FFA concentrations for Merino sheep showed higher concentra-
tions than that of Blackhead sheep in all of the sampling periods that took place before 
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µmol/l in the 1st and 2nd sampling periods respectively, and then gradually decreased to 
678.5 (516, 1127.2) µmol/l in the 3rd sampling period. After parturition, in the 4th sam-
pling period, it dropped to 122.5 (81.2, 280.5) µmol/l as seen in figure 6.  
 
Statistical analysis showed that there were significant differences (p<0.05) between the 
4th sampling period (four weeks after parturition) and the other sampling periods be-
fore parturition. On the other hand, there was a significant difference between Black-
head and Merino sheep in the 1st, 2nd, and 3rd periods of sampling (before parturition), 
while there was no significant difference in the 4th sampling period (after parturition). 
 
 
 
 
 
 
 
 
Figure 6: Fatty acid concentrations (µmol/l) in the serum of Blackhead and Merino 
ewes around parturition 
 
4.2.4 β-hydroxybutyrate (BHB) 
4.2.4.1 β-hydroxybutyrate concentrations in all sheep 
Before parturition, the mean values of BHB were 0.38 ± 0.13, 0.28 ± 0.1 and 0.27 ± 
0.22 mmol/l in the 1st, 2nd, and 3rd sampling periods. After parturition (in the 4th sam-
pling period), 0.33 ± 0.11 mmol/l was recorded, as seen in figure 7. 
 
 
4.2.4.2 β-hydroxybutyrate concentrations in Blackhead sheep 
Before parturition, the mean value of BHB was 0.32 ± 0.12 mmol/l (1st sampling pe-
riod). It then gradually decreased in the 2nd to 0.21 ± 0.12 mmol/l, and then again to 
0.16 ± 0.05 in the 3rd sampling periods. After parturition, in the 4th sampling period, it 
increased to 0.30 ± 0.08 mmol/l as seen in figure 8.  
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Figure 7: BHB concentrations (mmol/l) in the serum of ewes around parturition 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: BHB concentration (mmol/l) in serum of Black and Merino ewes around par-
turition 
 
4.2.4.3 β-hydroxybutyrate concentrations in Merino sheep 
The mean value of BHB in the 1st sampling period was 0.43 ± 0.12 mmol/l (before 
parturition). It then decreased in the 2nd and 3rd sampling periods to 0.33 ± 0.22 mmol/l 
and 0.36 ± 0.26 mmol/l respectively. Four weeks after parturition (4th sampling pe-
riod), it was 0.35 ± 0.13 mmol/l as seen in figure 8. 
 
Statistical analysis showed that there were significant differences (p<0.05) between 
Blackhead and Merino sheep in the 1st, 2nd, and 3rd periods of sampling (before parturi-
tion), while there was no significant difference in the 4th sampling period (after parturi-
tion). 
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4.2.5 Tumor necrosis factor alpha (TNFα)  
4.2.5.1 TNFα concentrations in all sheep 
The median values of TNF α showed slightly high levels in all of the sampling periods 
before parturition; 30.4 (17.2, 78.5) (median, first, and third quartiles); 35.6 (13.6, 
54.3); and 26.6 (13, 39.9) ng/ml in the 1st, 2nd, and 3rd sampling periods respectively. 
After parturition, during the 4th sampling period, this level decreased to 19.1 (9.9, 
33.8) ng/ml, see figure 9. 
 
 
 
  
 
 
 
 
Figure 9: TNFα concentrations (ng/ml) in the serum of ewes around parturition 
 
4.2.5.2 TNFα concentrations in Blackhead sheep 
The median values of TNFα showed slightly high levels in all of the sampling periods 
before parturition; 26.2 (12.4, 43), 29.3 (12.7, 43.8), and 17.6 (11.5, 76.7) ng/ml in the 
1st, 2nd, and 3rd sampling periods, respectively. After parturition, during the 4th sam-
pling period this level decreased to 17.9 (8.4, 32.7) ng/ml, see figure 10. 
 
 
 
 
 
 
 
 
 
 
Figure 10: TNFα concentrations (ng/ml) in the serum of Blackhead and Merino ewes 
around parturition 
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4.2.5.3 TNFα concentrations in Merino sheep 
The median values of TNF α showed a slightly high level in all the sampling periods 
before parturition; 47.7 (19.7, 109.3), 43.3 (15.7, 69.1), and 30.5 (16.3, 81.8) ng/ml in 
the 1st, 2nd, and 3rd sampling periods respectively. After parturition, during the 4th sam-
pling period, this level slightly decreased to 30 (11.2, 39). ng/ml, see figure 10. 
 
Statistical analysis illustrated that there was no significant difference between Black-
head and Merino sheep in all sampling periods. There was also no significant differ-
ence between the different sampling periods in regard to time. 
 
4.2.6 Haptoglobin 
4.2.6.1 Haptoglobin concentrations in all sheep  
The mean values of haptoglobin concentrations were 0.15 g/l, 0.06 g/l, and 0.12 g/l in 
period 2 (3 w.b.p.), period 3, (1 w.b.p.), and period 4 (4 w.a.p.), respectively. These 
values showed lower concentrations before parturition in period 3 (1 w.b.p.). Figure 11 
shows the variation of the haptoglobin concentration in 29 pregnant sheep. 
 
 
 
 
 
 
 
 
 
 
Figure11: Haptoglobin concentrations (g/l) in the serum of ewes around parturition 
 
4.2.6.2 Haptoglobin concentrations in Blackhead and Merino sheep 
Figure 12 shows the variation of Haptoglobin concentrations in Blackhead and Merino 
sheep. 
 
 
432 
H
ap
to
gl
ob
in
 (g
/l)
 
0.5 
0.4 
0.3 
0.2 
0.1 
  0.0 
3 W. b.p . 1 W. b.p. 4 W. a.p.
 52
 
 
 
 
 
            
 
Figure 12: Haptoglobin concentrations (g/l) in the serum of Blackhead and Merino 
ewes around parturition 
 
 
4.2.7 Albumin, R.R. 22-29 g/l (BICKHARDT 1992) 
4.2.7.1 Albumin concentrations in all sheep 
The mean values of Albumin concentrations were 38.51, 36.88 g/l, 30.64 g/l, and 
25.41 g/l in period 1(5 w.b.p.), period 2 (3 w.b.p.), period 3, (1 w.b.p.), and period 4 (4 
w.a.p.) respectively. These indicated that there was a slight increase in the Albumin 
concentrations in all the periods before parturition which then decreased to the normal 
concentrations after parturition. Figure 13 shows the variation in Albumin concentra-
tions of all sheep during the investigation time. 
 
 
 
 
 
 
 
 
 
Figure13: Albumin concentrations (g/l) in the serum of ewes around parturition 
 
 
 
sampling
432
H
ap
to
gl
ob
in
 (g
/l)
0,9
0,8
0,7
0,6
0,5
0,4
0,3
0,2
0,1
00,0
       race
 European Blackhead 
 Sheep
 Merino
3 W. b.p. 1 W. b.p. 4 W. a.p.
.
.
.
.
.
.
.
.
.
0.0
4321
Al
bu
m
in
 (g
/l)
60
50
40
30
20
10
0
5 W. b.p. 3 W. b.p. 1 W. b.p. 4 W. a.p.
Al
bu
m
in
 (g
/l)
aa
c b 
 53
4.2.7.2 Albumin concentrations in Blackhead and Merino sheep 
 Figure 14 shows the variation in Albumin concentrations in Blackhead in comparison 
to that of Merino sheep during the periods of study. The statistical analysis illustrated 
that there was no significant difference between Blackhead and Merino sheep in all 
periods of sampling.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Albumin concentrations (g/l) in the serum of Blackhead and Merino ewes 
around parturition 
 
4.2.8 Creatinkinase (CK), R.R 13- 230 U/l 
4.2.8.1 Creatinkinase activity in all sheep 
The mean values of CK in 29 pregnant ewes were 125.23 U/l, 116.97 U/l, 90.38 U/l, 
and 87.93 U/l in period 1(5 w.b.p.), period 2 (3 w.b.p.), period 3, (1 w.b.p.), and period 
4 (4 w.a.p) respectively. These values showed that CK was within normal levels in all 
period of sampling, Figure 15 shows the variation in CK activities in all sheep during 
the investigation time. 
 
4.2.8.2 Creatinkinase activity in Blackhead and Merino sheep 
Figure 16 shows the variation in the activity of CK in Blackhead sheep in comparison 
to that of Merino sheep. The statistical analysis of CK showed that there was signifi-
cant difference (p<0.05) between Blackhead and Merino sheep in the 1st sampling pe-
riod while there was no significant difference in the other periods of sampling. On the 
other hand regarding time of sampling there was significant difference (p<0.05) be-
tween the 1st and 3rd sampling periods. Also there was significant difference between 
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the 1st and 4th sampling periods. Significant difference was shown also between the 2nd 
and 4th sampling periods. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure15: CK activity (U/l) in the serum of ewes around parturition 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: CK activity (U/l) in the serum of Blackhead and Merino ewes around partu-
rition 
 
4.2.9 Gamma Glutamyl Transferase (GGT), R.R 12-60 U/l (ROSSOW and 
BOLDUAN, 1994) 
 
4.2.9.1 GGT activity in all sheep 
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tively. These values ranged within normal GGT activity in all sampling periods. Figure 
17 shows the variation of GGT activity of all sheep during the investigation time. 
 
 
 
 
 
 
 
 
 
Figure 17: GGT activity (U/l) in the serum of ewes around parturition 
 
4.2.9.2 GGT activity in Blackhead and Merino sheep 
Figure 18 shows the variation of GGT activity of Blackhead sheep in comparison to 
Merino sheep. The statistical analysis of GGT showed no significant difference be-
tween Blackhead and Merino sheep in all periods of sampling.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: GGT activity (U/l) in the serum of Blackhead and Merino ewes around par-
turition 
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4.2.10 Glutamat-Dehydrogenase (GLDH), R.R. ≤ 19.8 U/l (ROSSOW and 
BOLDUAN, 1994) 
4.2.10.1 GLDH activity in all sheep 
In all periods of sampling in all sheep, the mean values of GLDH ranged within nor-
mal levels. GLDH activities were 6.5 U/l, 6.04 U/l, 7.02 U/l, and 21.32 U/l in period 
1(5 w.b.p.), period 2 (3 w.b.p.), period 3, (1 w.b.p.), and period 4 (4 w.a.p.) respec-
tively. Figure 19 shows the variation of GLDH activity of 29 pregnant ewes during the 
investigation periods. 
 
4.2.10.2 GLDH activity in Blackhead and Merino sheep 
Figure 20 shows the variation in GLDH activity in Blackhead sheep in comparison to 
that of Merino sheep. The statistical analysis showed that there was no significant dif-
ference between Blackhead and Merino sheep in all periods of sampling. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure19: GLDH activity (U/l) in the serum of ewes around parturition 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: GLDH (U/l) in the serum of Blackhead and Merino ewes around parturition 
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4.2.11 Total protein, R.R. (60-79 g/l) 
4.2.11.1 Total protein concentrations in all sheep  
Figure 21 shows the variation of the total protein concentration of 29 pregnant ewes 
during the investigation time.  The mean protein concentration were 7.19 g/l, 66.89 g/l, 
52.9 g/l, and 47.67 g/l in period 1(5 w.b.p.), period 2 (3 w.b.p.), period 3, (1 w.b.p.), 
and period 4 (4 w.a.p.) respectively. These values indicate a slightly decrease in the 
protein concentration in the 3rd and 4th periods in comparison to the normal protein 
concentration. 
 
 
 
 
 
 
 
 
 
Figure 21: Total protein concentrations (g/l) in the serum of ewes around parturition 
 
4.2.11.2 Total protein concentrations in Blackhead and Merino sheep 
Figure 22 shows the variation of protein concentrations in Blackhead sheep in com-
parison to those of Merino sheep. The statistical analysis illustrated that there was no 
significant difference between Blackhead and Merino sheep in all sampling periods.  
 
 
 
 
 
 
 
 
 
 
Figure 22: Total protein concentrations (g/l) in the serum of Blackhead and Merino 
ewes around parturition 
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4.2.12 Cholesterol, R. R. (1.5-2.5 mmol/l) 
4.2.12.1 Cholesterol concentrations in all sheep  
The mean values of cholesterol concentrations in all sheep were 1.93 mmol/l, 1.93 
mmol/l, 1.6 mmol/l, and 1.3 mmol/l in period 1 (5 w.b.p.), period 2 (3 w.b.p.), period 
3, (1 w.b.p.), and period 4 (4 w.a.p.) respectively. These concentrations indicate a 
slight decrease in the cholesterol concentration in period 3 (1 w.b.p.) and in period 4 (4 
w.a.p.). 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Cholesterol concentrations (mmol/l) in the serum of ewes around parturi-
tion 
 
4.2.12.2 Cholesterol concentration in Blackhead and Merino sheep 
Figure 24 shows the variations of cholesterol concentrations in Blackhead sheep in 
comparison to Merino sheep. The statistical analysis showed there was no significant 
difference between Blackhead and Merino sheep. On the other hand, there was a sig-
nificant difference between period 3 from one side and periods 1 and 2 from the other 
side. Also there was significant difference between period 4 from one side and periods 
1 and 2 from the other side.  
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Figure 24: Cholesterol concentrations (mmol/l) in the serum of Blackhead and Merino 
ewes around parturition 
 
4.2.13 Iron, R. R. (13-44 µmol/l, FÜRLL et al. 1981) 
4.2.13.1 Iron concentration in all sheep 
Figure 25 shows the variations in the iron concentrations of all pregnant sheep during 
the time of study. The mean values of iron concentrations were 47.2 µmol/l, 46.4 
µmol/l, 40.7 µmol/l, and 16.5 µmol/l in period 1(5 w.b.p.), period 2 (3 w.b.p.), period 
3, (1 w.b.p.), and period 4 (4 w.a.p.) respectively. These concentrations show a slight 
decrease in period 3 (1 w.b.p.), followed by a sharp decrease after parturition (4 
w.a.p.).  
 
 
 
 
 
 
 
 
            
Figure 25: Iron concentrations (µmol/l) in the serum of ewes around parturition 
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4.2.13.2 Iron concentration in Blackhead and Merino sheep 
Figure 26 shows the variation of the iron concentrations of Blackhead sheep in com-
parison to Merino sheep. The statistical analysis illustrated that there was no signifi-
cant difference between Blackhead and Merino sheep in all sampling periods. How-
ever, regarding time of sampling, there were significant differences p<0.05 between 
the 1st, 3rd and 4th periods. There were also significant differences between the 2nd, 3rd, 
and 4th periods. 
 
 
 
 
 
 
 
 
 
Figure 26: Iron concentrations (µmol/l) in the serum of Blackhead and Merino ewes 
around parturition 
 
4.3 Haematological parameters 
4.3.1 Haematological parameters in all sheep 
Table 1 shows the mean values of different haematological parameters in 29 pregnant 
ewes before and after parturition. 
 
Table 1: Haematological parameters of all sheep before and after parturition 
Time Hb (mmol/l) 
Hk 
(l/l) 
MCH 
(f mol) 
MCV 
(f l) 
MCHC 
(mmol/l) 
 THC 
(G/l) 
LC 
(G/l) 
RBC 
(T/l) 
R.R.  5.6-9.3 0.27-0.4 0.6-0.7 28-40 19-23 
280-
650 5-11 7-11 
5 w 8.47 ± 0.6 
0.37 
± 0.17 
0.78 
± 0.03 
31.75 
± 1.9 
24.5 
± 0.7 
408 
± 143 
5.5 
± 1.12 
10.86 
± 0.69 
3 w 7.9 ± 0.7 
0.32 
± 0.03 
0.76 
± 0.03 
31.35 
± 1.8 
24.3 
± 0.8 
461 
± 162 
5.4 
± 1 
9.7 
± 2.5 
1 w 7.57 ± 0.6 
0.29 
± 0.02 
0.8 
± 0.03 
31.55 
± 1.5 
25.3 
± 0.7 
466 
± 154 
5.8 
± 1.1 
8.5 
± 2.5 
4 w 6.9 ± 0.8 
0.29 
± 0.03 
0.7 
± 0.08 
29.6 
± 6.3 
23.4 
± 0.6 
650 
± 148 
6.08 
± 1.1 
8.9 
± 2.4 
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4.3.2 Haematological parameters in Blackhead sheep  
Table 2 shows the mean values of different haematological parameters in Blackhead 
sheep before and after parturition. 
 
Table 2: Haematological parameters of Blackhead sheep before and after parturition 
Time Hb (mmol/l) 
Hk 
(l/l) 
MCH 
(f mol) 
MCV 
(f l) 
MCHC 
(mmol/l) 
THC 
(G/l) 
LC 
(G/l) 
RBC 
(T/l) 
R.R.  5.6-9.3 0.27-0.4 0.6-0.7 28-40 19-23 
280-
650 5-11 7-11 
5 w 8.4 ± 0.6 
0.4 
± 0.26 
0.76 
± 0.04 
30.3 
± 1.7 
25 
± 0.7 
448 
± 129.7
5.6 
± 1 
11 
± 0.5 
3 w 8.2 ± 0.5 
0.33 
± 0.01 
0.74 
± 0.03 
30.03 
± 1.6 
24.8 
± 0.7 
520.7 
± 127.3
5.2 
± 1 
9.4 
± 3.7 
1 w 7.8 ± 0.58 
0.3 
± 0.02 
0.77 
± 0.03 
30.3 
± 1 
25.6 
± 0.8 
490 
± 157 
5.5 
± 0.6 
9 
± 2.8 
4 w 7.3 ± 0.65 
0.3 
± 0.02 
0.7 
± 0.03 
29.7 
± 1.7 
23.7 
± 0.6 
641 
± 184.3
6 
± 1.2 
9.4 
± 3.1 
 
 
4.3.3 Haematological parameters in Merino sheep 
Table 3 shows the mean values of different haematological parameters in Merino 
sheep before and after parturition. 
 
Table 3: Haematological parameters of Merino sheep before and after parturition 
 
All the haematological parameters ranged within normal levels in all periods of sam-
pling (before and after parturition).  
 
Time Hb (mmol/l) 
Hk 
(l/l) 
MCH 
(f mol) 
MCV 
(f l) 
MCHC 
(mmol/l) 
THC 
(G/l) 
LC 
(G/l) 
RBC 
(T/l) 
R.R.  5.6-9.3 0.27-0.4 0.6-0.7 28-40 19-23 
280-
650 5-11 7-11 
5 w 8.5 ± 0.5 
0.35 
± 0.02 
0.7 
± 0.02 
32.98 
± 1.1 
24.2 
± 0.5 
372.3 
± 148.5 
5.5 
± 1.2 
10.7 
± 0.7 
3 w 7.7 ± 0.7 
0.32 
± 0.036 
0.7 
± 0.02 
32.33 
± 1.2 
24.09 
± 0.6 
417.1 
± 175.2 
5.6 
± 1 
10 
± 1 
1 w 7.3 ± 0.6 
0.29 
± 0.02 
0.8 
± 0.02 
32.4 
± 1.1 
25.1 
± 0.7 
449 
± 157 
6 
± 1.4 
8.1 
± 2.4 
4 w 6.6 ± 0.7 
0.28 
± 0.03 
0.7 
± 0.11 
29.5 
± 1.2 
23.1 
± 0.5 
657 
± 115 
6.2 
± 1.4 
8.4 
± 1.4 
 62
4.3.4 Statistical analyses of haematological parameters 
4.3.4.1 Haemoglobin concentration (Hb) 
There was significant difference (p<0.05) between Blackhead and Merino sheep in the 
4th period (four weeks after parturition), while there was no significant difference in 
the other periods of sampling (before parturition). Furthermore, regarding time of 
sampling, there was a significant difference (p<0.05) between the 1st period (five 
weeks before parturition) and the other periods of sampling. There was no significant 
difference between the 2nd period (four weeks before parturition) and the 3rd period 
(one week before parturition). There was also a significant difference between the 4th 
period and the other periods of sampling. 
 
4.3.4.2 Haematocrite (HK) 
Statistical analysis showed that there were significant differences between Blackhead 
and Merino sheep in all periods of sampling. Furthermore, regarding time of sampling, 
there were significant differences between the 1st, 3rd, and the 4th periods. There was 
no significant difference between the 2nd period and the other sampling periods. 
 
4.3.4.3 Mean corpuscular volume (MCV)  
There were significant differences between Blackhead and Merino sheep in all period 
of sampling. Furthermore, regarding time of sampling, there was no significant differ-
ence between the varying periods of sampling. 
 
4.3.4.4 Mean corpuscular haemoglobin (MCH) 
There were significant differences (p<0.05) between Blackhead and Merino sheep in 
the 2nd, 3rd, and the 4th periods. There was no significant difference in the 1st period.  
Regarding time of sampling, there were no significant differences between the 1st, 2nd, 
and the 3rd periods. There were, however, significant differences between the 2nd and 
the 3rd period. There were also significant differences between the 4th period and the 
other periods of sampling (1, 2, and 3). 
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4.3.4.5 Mean corpuscular hemoglobin concentration (MCHC) 
There were significant differences between Blackhead and Merino sheep in the 1st, 2nd, 
ands 4th periods. There was no significant difference in the 3rd period. 
Regarding the time of sampling, there were significant differences between the 3rd pe-
riods and the 1st, 2nd, and 3rd sampling periods. There was no significant difference 
between the 1st and 2nd periods. 
 
4.3.4.6 Thrombocytes count (THC)  
There were no significant differences between Blackhead and Merino sheep in all pe-
riods of sampling. Regarding time of sampling, there was significant difference be-
tween the 4th periods and the other three periods of sampling. 
 
4.3.4.7 Leukocytes (LC) 
There was no significant difference between Blackhead and Merino sheep in all peri-
ods of sampling. Regarding the time of sampling, there was no significant difference 
between all periods of sampling. 
 
4.3.4.8 Erythrocytes 
There was significant difference between Blackhead and Merino sheep in the 3rd and 
the 4th periods. Regarding the time of sampling, there were significant differences be-
tween the 1st, 3rd, and the 4th periods.  
 
Table 4: Degree of correlation between biochemical parameters and TNFα in Black-
head sheep before and after parturition 
  
** Correlation is significant at the 0.01 level (2. tailed) 
*   Correlation is significant at the 0.05 level (2.tailed) 
 Glucose 
(mmol/l) 
BHB 
(mmol/l) 
FFA 
(µmol/l) 
Insulin 
(nmol/l) 
BHB (mmol/l) 0.312**    
FFA (µmol/l) 0.442** 0.462**   
Insulin (nmol/l)      0.025       - 0.134 - 0.313  
TNFα (ng/ml)    - 0.079         0.278   0.320* - 0.277 
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There was a significant positive correlation between the following: 
• BHB and glucose 
• FFA and BHB 
• FFA and TNFα  
 
There was, however, a negative correlation between fatty acids and insulin. 
 
Table 5: Degree of correlation in Merino sheep between biochemical parameters and 
TNFα before and after parturition 
 
** Correlation is significant at the 0.01 level (2. tailed) 
*   Correlation is significant at the 0.05 level (2.tailed) 
  
There was a significant positive correlation between the following: 
• β-hydroxybutyrate and glucose 
• Free fatty acids and β-hydroxybutyrate 
• Free fatty acids and TNFα  
 
There was, however, a significant negative correlation between fatty acids and insulin. 
 
 Glucose 
(mmol/l) 
BHB 
(mmol/l) 
FFA 
(µmol/l) 
Insulin 
(nmol/l) 
BHB (mmol/l) 0.309**    
FFA (µmol/l) 0.404** 0.544**   
Insulin (nmol/ml)       0.025       - 0.092 - 0.310*  
TNFα (ng/ml)    - 0.248         0.268   0.249* - 0.170 
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5 Discussion 
 
Method 
 
The present study was directed in order to investigate the relationship between meta-
bolic parameters and cytokine TNFα in late pregnant ewes. It was directed also to 
know whether TNFα plays a role in the pathogenesis of pregnancy toxaemia. The in-
vestigation was occurred in two sheep races (Merino and Blackhead), which are sus-
ceptible to pregnancy toxaemia (ketosis) in late gestation. 
 
Characterization of metabolic parameters in the late pregnant ewes 
The results of the glucose measurements showed a significant increase (4.2 ± 0.86 
mmol/l) in period 1 (5 weeks before parturition), and declined with advancing gesta-
tion (2.9 ± 0.73 mmol/l) in period 3 (1 w. b. p.), see figure 1. 
The obtained results were within normal levels of glucose (reference range 2.2-3.3 
mmol/l, KRAFT and DÜRR 2005), and in agreement with those obtained by Al-
MUJALLI et al. (2008), who recorded that blood glucose levels in healthy pregnant 
ewes was 2.7 ± 0.24 mmol/l, and in ewes suffering from pregnancy toxemia was 1.02 
± 0.14 mmol/l. 
 
There are many other investigations showing low blood glucose levels in ketotic un-
derfed ewes suffering from pregnancy toxemia (GALL and FEKETE 1982, BICK-
HARDT et al. 1989, SINGH et al. 1992, HENZE et al. 1994, ROUBIES et al. 2003, 
EL-DIN et al. 2005, SCHLUMBOHM and HARMEYER 2008). 
 
These obtained findings illustrated the adaptation of maternal glucose metabolism dur-
ing pregnancy, as glucose is a major limiting nutrient of fetal growth to meet the in-
creasing fetal demands and maternal energy requirements of pregnancy (BATTAGLIA 
and MESCHIA 1988, Bell 1993, BELL and BAUMAN, 1997). It is believed that good 
nutrition in late pregnancy prevented sheep to supposed hypoglycemia and pregnancy 
toxemia (DURAK and ALTINER 2006).  
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The median values of insulin concentration in period 1 (5 w.b.p.) were 0.13 (0.08, 
0.23) nmol/l (median, first, and third quartiles). Almost the same values were obtained 
in period 2 (3 w.b.p.) and period 3 (1 w.b.p.) recording 0.12 (0.09, 0.21) and 0.12 
(0.09, 0.18) respectively. Then increased in period 4 (4 w.a.p.) to 0.22 (0.18, 0.36) 
nmol/l, see figure 3. These results agreed with those obtained by RICHTER (2000). 
 
During the last third of gestation, the decreased insulin concentrations were postulated 
to be a result of the decreased response of pancreas to insulinotropic agents (LOMAX 
et al. 1979). Through the creation of an environment which supports minimizing pe-
ripheral glucose utilization and maximizing glucose extraction of the gravid uterus, 
reducing insulin secretion during pregnancy is proposed to be beneficial to fetal well 
being (CONNOLLY et al. 2004). Additionally, the sensitivity of peripheral tissues to 
insulin is reduced (HAY et al. 1988, PETERSON 1993). 
 
In ketotic pregnant sheep, low insulin levels and therapeutic effect of insulin treatment 
support the hypothesis that insulin plays a causative role in the pathogenesis of ovine 
ketosis (HENZE et al. 1998). 
 
The lipogenic effect of insulin is well recognized (BROCKMAN 1978). A drop in 
plasma insulin concentration triggers lipolysis in adipose tissue and elevates plasma 
free fatty acids concentration. Lipid mobilization is, however, not a major ketogenic 
stimulus without a contribution from the liver (MAYES and FELTS 1967). 
 
Concerning the results of FFA, high concentrations were recorded in all periods of 
sampling before parturition; period 1 (5 w. b. p.), period 2 (3 w. b. p.), and period 3 (1 
w. b. p.). The median values were 976 (544, 1160) µmol/l (median, first, and third 
quartiles); 759 (568.7, 1313.2) µmol/l; and 523.5 (387.5, 931.2) µmol/l, respectively. 
These results are comparable with R. R. < 600 µmol/l (KRAFT and DÜRR 2005). 
Free fatty acid concentration is significantly decreased in period 4 (4 w. a. p.), see fig-
ure 5. 
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The elevated results of FFA coincide with those recorded by SINGH et al. (1992), 
PETTERSON et al. (1994), EL-DIN et al. (2005), and KULSCAR (2006). The ob-
tained finding explained that increased levels of cortisol (due to stress caused by preg-
nancy) lead to an increase of the FFA concentration (FLEMING 1997). Another rea-
son for this situation may be due to increased mobilization of adipose tissue to supply 
FFA as an alternative maternal energy source to meet the energy requirements for a 
fast growing fetus (PETHICK et al. 1983, LLIOU and DEMARNE 1987, and BODEN 
1996). 
 
The mean values of BHB in all periods of sampling, period 1 (5 w. b. p.), period 2 (3 
w. b. p.), period 3 (1 w. b. p.), and period 4 (4 w. a. p.) were 0.38 ± 0.13 mmol/l, 0.28 
± 0.1 mmol/l, 0.27 ± 0.22 mmol/l and 0.33 ± 0.1 mmol/l respectively. These values 
indicate normal levels of BHB before and after parturition, compared with subclinical 
ketosis (BHB > 1.0 mmol/l) or clinical ketosis BHB > 1.6 mmol/l (HENZE et al. 
1994). 
The results of haematological parameters (Hb, HK, MCH, MCV, MCHC, THC, and 
RBC) showed normal levels indicating that all pregnant ewes didn’t suffer from ane-
mia (GUPTA etal. 2008). The results of leukocytic count (LC) showed also normal 
levels and there was no significant correlation between leukocytic count and TNFα 
concentrations which may support that the measured TNFα increasement was due to 
the adipocytes. On the other hand, activation of Leukocytes occurs in case of preg-
nancy toxaemia accompanied with elevation of their TNFα production (SACKS et al. 
1999). 
 
Comparison between the Blackhead and Merino breed in the metabolic parame-
ters in the late gestation 
The results of glucose measurement illustrated that there was a significant difference 
(p<0.05) between Blackhead and Merino breed in period 1 (5 weeks before parturi-
tion), while there was no difference in the other periods of sampling, see figure 2. 
Measured insulin values showed that there was no significant difference between 
blackhead and merino breed in all periods of sampling, see figure 4. 
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The median values of FFA in Blackhead sheep were 671 (499.7, 1028) µmol/l (me-
dian, first, and third quartiles) in period 1 (5 w. b. p.); 621.5 (434.2, 761) µmol/l in 
period 2 (3 w. b. p.); and 339 (224.7, 543) µmol/l in period 3 (1 w. b. p.), see figure 6. 
For Merino sheep, the values of free fatty acids were 1041.5 (920.2, 1355) µmol/l in 
period 1 (5 w. b. p.); 920.5 (667.7, 1411.2) µmol/l in period 2 (3 w. b. p.); and 678.5 
(516, 1127.2) µmol/l in period 3 (1 w. b. p.), see figure 6. 
 
These finding showed significant increase (p<0.05) in the level of free fatty acid in 
Merino sheep than in Blackhead sheep before parturition, while there was no signifi-
cant difference after parturition. 
The obtained results of BHB revealed that there was a significant increase in the con-
centrations of BHB in Merino breed compared to Blackhead breed before parturition, 
while there was no significant difference after parturition, see figure 8. 
The elevation of FFA and BHB concentrations in Merino breed before parturition can 
be explained by the increasing of the average numbers of Merino’s lambs ( 2.18/ewe) 
in comparison to the average numbers of Blackhead’s lambs (1.58 /ewe) which caus-
ing increase of the energy requirements for late pregnant multiparous Merino ewes to 
meet the fetal demands. This in turn results in the increase of lipolysis producing more 
FFA and BHB. 
 
In Merino and Blackhead sheep there was a significant positive correlation between 
the following: 
• BHB and glucose 
• FFA and β-hydroxybutyrate 
• FFA and TNFα  
 
There was a significant negative correlation between FFA and insulin. 
The obtained results indicate that these ewes did not suffer from subclinical pregnancy 
toxaemia, which was indicated by BHB concentration less than 0.7 mmol/l 
(MOGHADDAM and HASSANPOUR 2008). 
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Interaction between fat metabolism and TNFα  
Classically, the immune, endocrine, neural, and metabolic systems were usually stud-
ied in isolation with the assumption that these systems operate more or less independ-
ently of each others. In recent years, however, the interconnected nature of all these 
control systems became well established (KELLY et al. 2000, DRACKLEY and AN-
DERSEN 2006). Thus, these systems work together to maintain homeostasis under the 
wide range of physical, pathological, and physiological states through which animals 
pass during their lifetimes, given the current understanding of the interdependency of 
all the detection and response systems in the body. It does not seem surprising that 
molecules traditionally thought of as products of the immune system (such as cyto-
kines) may be produced by metabolic tissues such as adipose and muscle. They also 
can affect metabolic pathways traditionally thought to be only controlled via substrate 
and hormonal regulation of enzyme activity. 
 
Adipose tissue produces a variety of adipocytokines that have been linked to insulin 
resistance in humans (WELLEN and HOTAMISLIGIL 2003). Of these, TNFα is one 
of the most studied (HOTAMISLIGIL et al.1993, GASIC et al.1998, RUAN et al. 
2002). Fat ewes had greater plasma concentration of TNFα than thin ewes (DANIEL 
et al. 2003), resulting in increased lipolysis, and increased circulatory free fatty acids 
levels (GASIC et al. 1998, GREEN et al. 2004 and PLOMGAARD et al. 2008). 
 
The measurements of TNFα showed elevated levels in all period of sampling before 
parturition. The median values of TNFα were 30.4 (17.2, 78.5) ng/ml (median, first, 
and third quartiles); 35.6 (13.6, 54.3) ng/ml; and 26.6 (13, 39.9) ng/ml in period 1(5 
w.b.p.), period 2 (3 w.b .p.), and period 3 (1 w.b.p.) respectively. These values de-
creased to 19.1 (9.9, 33.8) ng/ml (4 weeks after parturition), see figure 9. There was a 
significant positive correlation between FFA and TNFα.  
 
These finding may be confirmed by the results of investigation performed by JIANG 
et al. (2004), who recorded that the level of cytokine TNFα increased during preg-
nancy, and then subsequently decreased after parturition. This suggested that there is a 
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close relationship between cytokine TNFα and gestation, which play an important role 
in maintain gestation. 
 
Cytokine TNFα may originate from various sources, including immune system cell 
macrophage, adipose tissue (GASIC et al. 1998), or placenta in which cytokine TNFα 
both induce maternal gestational insulin resistance and alter nutrient transport to the 
fetus. Maternal obesity enhanced the placental inflammatory response in ewes at mid 
gestation, possibly as result of increased free fatty acids (ZHU et al. 2010). 
 
The role of TNFα in pathogenesis of pregnancy toxemia was examined by many inves-
tigators (GREER et al. 1994, KUPFERMINC 1994, VINCE 1995, BENYO 1997, 
CONRAD et al. 1997, CONRAD et al. 1998, HUNG et al. 2004, YARIM et al. 2007, 
LEWIS et al. 2009, and ZHU et al. 2010). They suggested that TNFα and other cyto-
kines participate in the aetiopathogenesis of pregnancy toxemia via its effect on tro-
phoblastic cell activation, which is a potential mediator of inflammatory response in 
pregnancy toxemia (ROBERTS et al. 1989). An excessive systematic inflammatory 
reaction and increased production of inflammatory cytokine occur in pregnancy toxe-
mia. 
 
From the recorded data, it can be concluded that fat mobilization occurred in the pre-
partum clinically healthy ewes with a significant increase in the levels of free fatty 
acids and also that there is an increase in the proinflammatory cytokine TNFα at late 
gestation, which predispose ewe to pregnancy toxemia, and can aid in the diagnosis of 
the disease. Further studies, based on ewes suffering from pregnancy toxemia, are 
needed to illuminate the potential effect of such cytokines in aetiopathogenesis of the 
disease. 
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Pregnancy toxaemia (ketosis) is a metabolic disease of ewes which occurs during the 
late gestation as a result of the inability of the pregnant ewe to maintain an adequate 
energy balance for the fast growing maternal fetal unit. As a result of energy defi-
ciency mobilization of lipid reserves results in a doubling of the plasma free fatty acid 
(FFA) giving rise to fatty liver and increased  ketone bodies β-hydroxybutyrate (BHB) 
in blood and urine. It is associated with a higher rate of mortality and causes severe 
economic losses. 
The objective of this study was directed at investigating the relationship between 
metabolic parameters and cytokine TNFα, to check the interaction between the TNFα 
and fat metabolism in late pregnant ewes of different breeds, and whether TNFα play a 
role in the pathogenesis of pregnancy toxaemia, which may serve as marker to early 
diagnosis of the disease. 
In this study, 29 pregnant and clinically healthy ewes (16 Merino, 13 Blackhead) were 
selected out of a flock of sheep. Blood samples were collected at 5, 3, and 1 week be-
fore parturition (b.p.) and also 4 weeks after parturition (a.p.). The average numbers of 
lambs were 2.18 and 1.58 /ewe for Merino and Blackhead breeds respectively. The 
blood samples were analyzed for the following: 
¾ Concentration of metabolic parameters: glucose, insulin, free fatty acids (FFA), β-
hydroxybutyrate (BHB), albumin, total protein (TP), iron (Fe), glutamat-dehydro-
genase (GLDH), creatin kinase (CK), gamma-glutamyl-transferase (GGT), choles-
terol, haptoglobin. 
¾ Haematological parameters: Haematocrite (HK), haemoglobin concentration (HB), 
erythrocyte count (EC), leukocyte count (LC), mean corpuscular volume (MCV), 
 72
mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin con-
centration (MCHC). 
¾ Cytokine TNFα by using ovine TNFα ELISA assay. 
The results of glucose concentration of pregnant ewes showed significant increase (3.8 
mmol/l) in five weeks b.p. and declined with advancing gestation (2.6 mmol/l) one 
week b.p. Insulin concentration remained constant with an average of 0.11 nmol/l b.p., 
and then significantly increased to 0.22 nmol/l four weeks a.p.  
Maximal FFA concentrations were found at five weeks b.p. (976 µmol/l). The levels 
of FFA showed high levels b.p. compared with reference range (R.R. < 600 µmol/l), 
and the FFA levels significantly decreased postpartum (four weeks b.p.). while there 
was significant increasing (p<0.05) in the level of FFA in Merino sheep than in Black-
head sheep b.p. On the other hand there was no significant difference a.p.  
The mean values of BHB in all periods of sampling, period 1(5 w.b.p.), period 2 (3 
w.b.p.), period 3 (1 w.b.p.), and period 4 (4 w.a.p.) were 0.37 mmol/l, 0.23 mmol/l, 
0.17 mmol/l and 0.3 mmol/l respectively. The mean of BHB indicated normal levels of 
BHB before and after parturition compared to subclinical ketosis (BHB > 1 mmol/l) 
and clinical ketoses (BHB > 1.6 mmol/l), and there was a significant difference 
(p<0.05) in the values of  BHB between Blackhead and Merino breeds before parturi-
tion while there was no significant difference after parturition. 
The concentration of TNFα showed elevated levels in all period of sampling before 
parturition. The TNFα values were 30.4 (17.2, 785.0) ng/ml (median, first, and third 
quartiles), 35.6 (13.6, 54.3), and 26.6 (13.0, 39.9) ng/ml in period 1(5 w.b.p.), period 2 
(3 w.b.p.), and period 3 (1 w.b.p.) respectively. These values decreased to 19.1 (9.9, 
33.8) ng/ml at 4 weeks after parturition. 
Statistical analysis showed that there was a positive correlation between free fatty ac-
ids and TNFα. This correlation means that adipose tissue produces TNFα causing insu-
lin resistance, which stimulates the lipolysis and leads to an increase of circulatory free 
fatty acids levels. 
It is concluded that fat mobilization occurs in the prepartum clinically healthy ewes 
with a significant increase in the levels of FFA, and also there is an increase in the pro-
inflammatory cytokine TNFα at late gestation which predisposes ewes to pregnancy 
toxaemia and can aid in the diagnosis of the disease. 
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Die Trächtigkeitstoxikose (Ketose) ist eine Stoffwechselkrankheit der Mutterschafe, 
die in der Spätträchtigkeit infolge Imbalancen des Energiestoffwechsels der trächtigen 
Mutterschafe durch die schnell wachsenden Föten auftritt. Infolge des Energiemangels 
werden Fettreserven mobilisiert. Das führt zu einem Anstieg der FFS- (Freie 
Fettsäuren) Konzentrationen im Plasma, zur Entwicklung einer Fettleber sowie zum 
Anstieg der Ketonkörper einschließlich BHB (β-Hydroxybutyrat)  in Blut und Harn. 
Dies geht mit einer höheren Mortalität sowie ökonomischen Verlusten einher. 
Ziel der Studie war es, Beziehungen zwischen TNFα und Stoffwechselparametern in 
der Spätträchtigkeit von Mutterschafen, potentielle Unterschiede zwischen zwei 
Schafrassen sowie eine ätiologische Bedeutung von TNFα in der Pathogenese der 
Ketose zu prüfen. 
Die Untersuchungen wurden an 29 klinisch gesunden Mutterschafen (16 
Merinofleischschafe [MFS], 13 Schwarzköpfige Fleischschafe [SK]) durchgeführt. 
Blutproben wurden fünf, drei, und eine Woche vor (a.p.) sowie vier Wochen nach dem 
Lammen (p.p.) entnommen. Die durchschnittliche Zahl der Lämmer waren 2,18 und 
1,58/Mutterschaf für MFS und SK Rasse bzw. In Serum bzw. Blut wurden untersucht: 
¾ die Stoffwechselparameter: Glucose, Insulin, FFS, BHB, Albumin, Gesamteiweiß, 
Eisen (Fe), Glutamat-Dehydrogenase (GLDH), Creatinkinase (CK), Gamma-
Glutamyl-Transferase (GGT), Cholesterol sowie Haptoglobin. 
¾ Die hämatologischen Parameter: Hämatokrit (Hk), Hämoglobin (Hb), Erythrozyten  
(EC), Leukozyten (LC) sowie die erythrozytären Rechenwerte mittleres 
korpuskuläres Volumen (MCV), mittlere korpuskuläre Hämoglobinkonzentration der 
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Einzelerythrozyten (MCH) sowie die mittlere korpuskuläre Hämoglobinkonzentrat-
ion (MCHC).  
¾ das Zytokin TNFα mittels eines ovinen TNFα ELISA assay. 
Die Glucosekonzentration der trächtigen Mutterschafe stieg signifikant bis auf 3,8 
mmol/l zum Ablammen an und fiel auf 2,6 mmol/l eine Woche p.p. ab. 
Die Insulinkonzentration blieb a.p. im Bereich von 0,11 nmol/l konstant, um bis vier 
Wochen p.p. signifikant auf 0,22 nmol/l anzusteigen  
Die maximalen FFS-Konzentrationen wurden fünf Wochen a.p. (976 µmol/l) 
gefunden, d.h., sie lagen über dem Referenzwert von < 600 µmol/l. Nach dem 
Lammen fiel die FFS-Konzentration signifikant bis vier Wochen p.p. ab. Bei den MFS 
waren a.p. die FFS-Konzentrationen signifikant (p<0.05) höher als bei den SK; p.p. 
bestanden keine gesicherten Unterschiede. 
Die BHB-Mittelwerte betrugen fünf Wochen a.p. 0,37 mmol/l, drei Wochen a.p. 0,23 
mmol/l, eine Woche a.p. 0,17 mmol/l sowie vier Wochen p.p. 0,30 mmol/l, d.h., sie 
befanden sich sowohl vor wie auch dem Lammen im physiologischen Bereich. Es 
bestanden keine gesicherten Unterschiede zwischen MFS sowie SK. 
Die TNFα-Konzentrationen waren mit 30,4 (17,2; 785,0) (Median; 1. und drittes Qua-
rtil) ng/ml fünf Wochen, mit 35,6 (13,6; 54,3) ng/ml drei Wochen und mit 26,6 (13,0; 
39,9) ng/ml a.p. nichtsignifikant höher als mit 19,1 (9,9; 33,8) ng/ml vier Wochen p.p.  
Die Korrelationsanalyse erbrachte mit r = 0,320 bei SK sowie r = 0,249 bei den MFS 
signifikant positive Korrelationen zwischen den TNFα- sowie FFS-Konzentrationen. 
Das unterstützt die These, dass das Fettgewebe via TNFα-Bildung eine Insulinresis-
tenz mit der Folge gesteigerter Lipolyse und erhöhter FFS-Konzentrationen im Blut 
fördert. 
Es kann geschlussfolgert werden, dass bei klinisch gesunden Mutterschafen am Ende 
der Trächtigkeit eine Fettmobilisierung mit gesteigerten FFS-Konzentrationen im Blut 
sowie gleichzeitig erhöhten Konzentrationen des proinflammatorischen Zytokins 
TNFα einsetzt. Diese Beziehungen können die Entstehung einer Trächtigkeitstoxikose 
begünstigen und zu diagnostischen Zwecken genutzt werden. 
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